0001652958 2026-01-01 2026-06-30 0001652958 2026-08-14 0001652958 2026-06-30 0001652958 2025-12-31 0001652958 us-gaap:PreferredStockMember 2026-06-30 0001652958 us-gaap:PreferredStockMember 2025-12-31 0001652958 us-gaap:SeriesDPreferredStockMember 2026-06-30 0001652958 us-gaap:SeriesDPreferredStockMember 2025-12-31 0001652958 2026-04-01 2026-06-30 0001652958 2025-04-01 2025-06-30 0001652958 2025-01-01 2025-06-30 0001652958 EDGM:SeriesDPreferredSharesMember 2025-12-31 0001652958 us-gaap:CommonStockMember 2025-12-31 0001652958 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001652958 us-gaap:RetainedEarningsMember 2025-12-31 0001652958 us-gaap:NoncontrollingInterestMember 2025-12-31 0001652958 EDGM:SeriesDPreferredSharesMember 2026-03-31 0001652958 us-gaap:CommonStockMember 2026-03-31 0001652958 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001652958 us-gaap:RetainedEarningsMember 2026-03-31 0001652958 us-gaap:NoncontrollingInterestMember 2026-03-31 0001652958 2026-03-31 0001652958 EDGM:SeriesDPreferredSharesMember 2024-12-31 0001652958 us-gaap:CommonStockMember 2024-12-31 0001652958 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001652958 us-gaap:RetainedEarningsMember 2024-12-31 0001652958 us-gaap:NoncontrollingInterestMember 2024-12-31 0001652958 2024-12-31 0001652958 EDGM:SeriesDPreferredSharesMember 2025-03-31 0001652958 us-gaap:CommonStockMember 2025-03-31 0001652958 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001652958 us-gaap:RetainedEarningsMember 2025-03-31 0001652958 us-gaap:NoncontrollingInterestMember 2025-03-31 0001652958 2025-03-31 0001652958 EDGM:SeriesDPreferredSharesMember 2026-01-01 2026-03-31 0001652958 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001652958 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001652958 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001652958 us-gaap:NoncontrollingInterestMember 2026-01-01 2026-03-31 0001652958 2026-01-01 2026-03-31 0001652958 EDGM:SeriesDPreferredSharesMember 2026-04-01 2026-06-30 0001652958 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001652958 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001652958 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001652958 us-gaap:NoncontrollingInterestMember 2026-04-01 2026-06-30 0001652958 EDGM:SeriesDPreferredSharesMember 2025-01-01 2025-03-31 0001652958 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001652958 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001652958 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001652958 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0001652958 2025-01-01 2025-03-31 0001652958 EDGM:SeriesDPreferredSharesMember 2025-04-01 2025-06-30 0001652958 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001652958 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001652958 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001652958 us-gaap:NoncontrollingInterestMember 2025-04-01 2025-06-30 0001652958 EDGM:SeriesDPreferredSharesMember 2026-06-30 0001652958 us-gaap:CommonStockMember 2026-06-30 0001652958 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001652958 us-gaap:RetainedEarningsMember 2026-06-30 0001652958 us-gaap:NoncontrollingInterestMember 2026-06-30 0001652958 EDGM:SeriesDPreferredSharesMember 2025-06-30 0001652958 us-gaap:CommonStockMember 2025-06-30 0001652958 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001652958 us-gaap:RetainedEarningsMember 2025-06-30 0001652958 us-gaap:NoncontrollingInterestMember 2025-06-30 0001652958 2025-06-30 0001652958 EDGM:SpainLeasesMember 2025-10-15 0001652958 EDGM:DCEstatesSolutionsMember 2025-10-15 0001652958 EDGM:BAIFMember 2025-10-15 0001652958 EDGM:StockOptionsMember 2026-04-01 2026-06-30 0001652958 EDGM:StockOptionsMember 2026-01-01 2026-06-30 0001652958 us-gaap:ConvertibleDebtSecuritiesMember 2026-04-01 2026-06-30 0001652958 us-gaap:ConvertibleDebtSecuritiesMember 2026-01-01 2026-06-30 0001652958 EDGM:StockOptionsMember 2025-04-01 2025-06-30 0001652958 EDGM:StockOptionsMember 2025-01-01 2025-06-30 0001652958 us-gaap:WarrantMember 2025-04-01 2025-06-30 0001652958 us-gaap:WarrantMember 2025-01-01 2025-06-30 0001652958 us-gaap:ConvertibleDebtSecuritiesMember 2025-04-01 2025-06-30 0001652958 us-gaap:ConvertibleDebtSecuritiesMember 2025-01-01 2025-06-30 0001652958 EDGM:PrivateOfferingMember 2025-01-01 2025-12-31 0001652958 EDGM:PrivateOfferingMember 2026-01-01 2026-06-30 0001652958 EDGM:PrivateOfferingMember 2026-06-30 0001652958 us-gaap:FairValueInputsLevel1Member 2026-06-30 0001652958 us-gaap:FairValueInputsLevel2Member 2026-06-30 0001652958 us-gaap:FairValueInputsLevel3Member 2026-06-30 0001652958 us-gaap:FairValueInputsLevel1Member 2025-12-31 0001652958 us-gaap:FairValueInputsLevel2Member 2025-12-31 0001652958 us-gaap:FairValueInputsLevel3Member 2025-12-31 0001652958 srt:ChiefExecutiveOfficerMember 2026-02-09 2026-02-10 0001652958 srt:ChiefFinancialOfficerMember 2026-02-09 2026-02-10 0001652958 EDGM:BoardMember 2026-02-09 2026-02-10 0001652958 srt:ExecutiveOfficerMember 2026-06-30 0001652958 srt:ExecutiveOfficerMember 2025-12-31 0001652958 EDGM:MarvikenTwoAbMember 2025-04-07 0001652958 EDGM:MarvikenTwoAbMember 2025-04-06 2025-04-07 0001652958 EDGM:BAIFMember 2025-10-15 0001652958 EDGM:BAIFMember 2026-02-22 0001652958 EDGM:BAIFMember 2026-06-30 0001652958 EDGM:JointVenturesMember 2026-06-30 0001652958 us-gaap:SeriesDPreferredStockMember 2025-12-10 0001652958 srt:OfficerMember us-gaap:SeriesDPreferredStockMember 2025-12-10 0001652958 EDGM:PrivateInvestorMember 2026-01-01 2026-06-30 0001652958 srt:DirectorMember 2026-01-01 2026-06-30 0001652958 EDGM:CashlessExerciseOfWarrantsMember EDGM:RestrictedCommonStockMember 2026-01-01 2026-06-30 0001652958 EDGM:CashlessExerciseOfWarrantsMember EDGM:WarrantsMember 2026-01-01 2026-06-30 0001652958 EDGM:ConvertibleNotesConversionMember 2026-01-01 2026-06-30 0001652958 us-gaap:RestrictedStockMember EDGM:SecuritiesPurchaseAgreementMember 2025-09-03 2025-09-04 0001652958 EDGM:ELOCMember us-gaap:CommonStockMember 2026-01-01 2026-06-30 0001652958 EDGM:FirstMoraOptionMember 2026-01-21 2026-01-22 0001652958 EDGM:SecondMoraOptionMember 2026-01-21 2026-01-22 0001652958 EDGM:FaulknerAndWajcenbergMember 2026-02-09 2026-02-10 0001652958 EDGM:OptionsInDisputeMember 2026-06-30 0001652958 EDGM:CryptoMiningMilestoneMember 2026-06-30 0001652958 us-gaap:OptionMember 2025-12-31 0001652958 us-gaap:OptionMember 2026-01-01 2026-06-30 0001652958 us-gaap:OptionMember 2026-06-30 0001652958 us-gaap:WarrantMember 2025-12-31 0001652958 us-gaap:WarrantMember 2026-01-01 2026-06-30 0001652958 us-gaap:WarrantMember 2026-06-30 0001652958 2022-01-31 0001652958 EDGM:August2025SPAMember 2025-08-15 0001652958 EDGM:August2025SPAMember 2025-08-14 2025-08-15 0001652958 EDGM:August2025SPAMember EDGM:OriginalIssueDiscountMember 2025-08-14 2025-08-15 0001652958 EDGM:August2025SPAMember EDGM:LegalFeesMember 2025-08-14 2025-08-15 0001652958 EDGM:August2025SPAMember 2026-01-01 2026-06-30 0001652958 EDGM:Sept2025ClearThinkNoteMember 2025-09-02 0001652958 EDGM:Sept2025ClearThinkNoteMember 2025-09-01 2025-09-02 0001652958 EDGM:Sept2025ClearThinkNoteMember EDGM:DefaultPenaltyMember 2026-01-01 2026-06-30 0001652958 EDGM:Sept2025ClearThinkNoteMember 2026-01-01 2026-06-30 0001652958 EDGM:Sept2025ClearThinkNoteMember 2026-06-30 0001652958 EDGM:Sept92025SPAMember 2025-09-09 0001652958 EDGM:Sept92025SPAMember 2025-09-08 2025-09-09 0001652958 EDGM:Sept92025SPAMember EDGM:OriginalIssueDiscountMember 2025-09-08 2025-09-09 0001652958 EDGM:Sept92025SPAMember EDGM:LegalFeesMember 2025-09-08 2025-09-09 0001652958 EDGM:Sept92025SPAMember 2026-01-01 2026-06-30 0001652958 EDGM:Sept92025SPAMember EDGM:InterestChargeMember 2026-01-01 2026-06-30 0001652958 EDGM:Sept152025SPAMember 2025-09-15 0001652958 EDGM:Sept152025SPAMember 2025-09-14 2025-09-15 0001652958 EDGM:Sept152025SPAMember EDGM:OriginalIssueDiscountMember 2025-09-14 2025-09-15 0001652958 EDGM:Sept152025SPAMember EDGM:LegalFeesMember 2025-09-14 2025-09-15 0001652958 EDGM:Sept152025SPAMember 2026-01-01 2026-06-30 0001652958 EDGM:Sept152025SPAMember 2026-06-30 0001652958 EDGM:Sept182025SPAMember 2025-09-18 0001652958 EDGM:Sept182025SPAMember 2025-09-17 2025-09-18 0001652958 EDGM:Sept182025SPAMember EDGM:OriginalIssueDiscountMember 2025-09-17 2025-09-18 0001652958 EDGM:Sept182025SPAMember EDGM:LegalFeesMember 2025-09-17 2025-09-18 0001652958 EDGM:Sept182025SPAMember EDGM:CommitmentSharesMember 2025-09-17 2025-09-18 0001652958 EDGM:Sept182025SPAMember 2026-01-01 2026-06-30 0001652958 EDGM:Sept182025SPAMember 2026-06-30 0001652958 EDGM:Sept232025SPAMember 2025-09-23 0001652958 EDGM:Sept232025SPAMember 2025-09-22 2025-09-23 0001652958 EDGM:Sept232025SPAMember EDGM:OriginalIssueDiscountMember 2025-09-22 2025-09-23 0001652958 EDGM:Sept232025SPAMember EDGM:LegalFeesMember 2025-09-22 2025-09-23 0001652958 EDGM:Sept232025SPAMember EDGM:DefaultPenaltyMember 2026-01-01 2026-06-30 0001652958 EDGM:Sept232025SPAMember 2026-01-01 2026-06-30 0001652958 EDGM:Sept232025SPAMember 2026-06-30 0001652958 EDGM:Sept232025SecondSPAMember 2025-09-23 0001652958 EDGM:Sept232025SecondSPAMember 2025-09-22 2025-09-23 0001652958 EDGM:Sept232025SecondSPAMember EDGM:OriginalIssueDiscountMember 2025-09-22 2025-09-23 0001652958 EDGM:Sept232025SecondSPAMember EDGM:LegalFeesMember 2025-09-22 2025-09-23 0001652958 EDGM:Sept232025SecondSPAMember EDGM:DefaultPenaltyMember 2026-01-01 2026-06-30 0001652958 EDGM:Sept232025SecondSPAMember 2026-01-01 2026-06-30 0001652958 EDGM:Sept232025SecondSPAMember 2026-06-30 0001652958 EDGM:Oct32025SPAMember 2025-10-03 0001652958 EDGM:Oct32025SPAMember 2025-10-02 2025-10-03 0001652958 EDGM:Oct32025SPAMember EDGM:OriginalIssueDiscountMember 2025-10-02 2025-10-03 0001652958 EDGM:Oct32025SPAMember 2026-06-30 0001652958 EDGM:Oct82025ConvNoteMember 2025-10-08 0001652958 EDGM:Oct82025ConvNoteMember 2025-10-07 2025-10-08 0001652958 EDGM:Oct82025ConvNoteMember 2026-06-30 0001652958 EDGM:Oct92025ClearThinkNoteMember 2025-10-09 0001652958 EDGM:Oct92025ClearThinkNoteMember 2025-10-07 2025-10-09 0001652958 EDGM:Oct92025ClearThinkNoteMember EDGM:OriginalIssueDiscountMember 2025-10-07 2025-10-09 0001652958 EDGM:Oct92025ClearThinkNoteMember 2026-06-30 0001652958 EDGM:Nov2025ConvNotePayableMember 2025-11-26 0001652958 EDGM:Nov2025ConvNotePayableMember 2025-11-25 2025-11-26 0001652958 EDGM:Nov2025ConvNotePayableMember EDGM:OriginalIssueDiscountMember 2025-11-25 2025-11-26 0001652958 EDGM:Nov2025ConvNotePayableMember 2026-06-30 0001652958 EDGM:Jan122026SPAMember 2026-01-12 0001652958 EDGM:Jan122026SPAMember 2026-01-11 2026-01-12 0001652958 EDGM:Jan122026SPAMember 2026-06-30 0001652958 EDGM:Jan272026SPAMember 2026-01-27 0001652958 EDGM:Jan272026SPAMember 2026-01-26 2026-01-27 0001652958 EDGM:Jan272026SPAMember 2026-06-30 0001652958 EDGM:Feb2026SPAMember 2026-02-24 0001652958 EDGM:Feb2026SPAMember 2026-02-23 2026-02-24 0001652958 EDGM:Feb2026SPAMember 2026-06-30 0001652958 EDGM:Mar2026SPAMember 2026-03-05 0001652958 EDGM:Mar2026SPAMember 2026-03-04 2026-03-05 0001652958 EDGM:Mar2026SPAMember 2026-06-30 0001652958 EDGM:May2026SPAMember 2026-05-20 0001652958 EDGM:May2026SPAMember 2026-05-19 2026-05-20 0001652958 EDGM:May2026SPAMember EDGM:OriginalIssueDiscountMember 2026-05-19 2026-05-20 0001652958 EDGM:May2026SPAMember 2026-06-30 0001652958 EDGM:June2026ConvNotePayableMember 2026-06-03 0001652958 EDGM:June2026ConvNotePayableMember 2026-06-02 2026-06-03 0001652958 EDGM:June2026ConvNotePayableMember EDGM:OriginalIssueDiscountMember 2026-06-02 2026-06-03 0001652958 EDGM:June2026ConvNotePayableMember 2026-06-30 0001652958 EDGM:ConversionOptionMember us-gaap:MeasurementInputPriceVolatilityMember 2026-01-01 2026-06-30 0001652958 EDGM:WarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2026-01-01 2026-06-30 0001652958 EDGM:ConversionOptionMember us-gaap:MeasurementInputExpectedDividendRateMember 2026-01-01 2026-06-30 0001652958 EDGM:WarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2026-01-01 2026-06-30 0001652958 EDGM:ConversionOptionMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-01-01 2026-06-30 0001652958 EDGM:WarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-01-01 2026-06-30 0001652958 EDGM:ConversionOptionMember us-gaap:MeasurementInputExpectedTermMember 2026-01-01 2026-06-30 0001652958 EDGM:WarrantsMember us-gaap:MeasurementInputExpectedTermMember 2026-01-01 2026-06-30 0001652958 EDGM:ConversionOptionMember us-gaap:MeasurementInputSharePriceMember 2026-01-01 2026-06-30 0001652958 EDGM:WarrantsMember us-gaap:MeasurementInputSharePriceMember 2026-01-01 2026-06-30 0001652958 EDGM:ConversionOptionMember us-gaap:MeasurementInputExercisePriceMember 2026-01-01 2026-06-30 0001652958 EDGM:WarrantsMember us-gaap:MeasurementInputExercisePriceMember 2026-01-01 2026-06-30 0001652958 EDGM:ConversionOptionMember 2026-06-30 0001652958 EDGM:WarrantsMember 2026-06-30 0001652958 EDGM:ConversionOptionMember us-gaap:MeasurementInputPriceVolatilityMember 2025-01-01 2025-12-31 0001652958 EDGM:WarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2025-01-01 2025-12-31 0001652958 EDGM:ConversionOptionMember us-gaap:MeasurementInputExpectedDividendRateMember 2025-01-01 2025-12-31 0001652958 EDGM:WarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2025-01-01 2025-12-31 0001652958 EDGM:ConversionOptionMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-01-01 2025-12-31 0001652958 EDGM:WarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-01-01 2025-12-31 0001652958 EDGM:ConversionOptionMember us-gaap:MeasurementInputExpectedTermMember 2025-01-01 2025-12-31 0001652958 EDGM:WarrantsMember us-gaap:MeasurementInputExpectedTermMember 2025-01-01 2025-12-31 0001652958 EDGM:ConversionOptionMember us-gaap:MeasurementInputSharePriceMember 2025-01-01 2025-12-31 0001652958 EDGM:WarrantsMember us-gaap:MeasurementInputSharePriceMember 2025-01-01 2025-12-31 0001652958 EDGM:ConversionOptionMember us-gaap:MeasurementInputExercisePriceMember 2025-01-01 2025-12-31 0001652958 EDGM:WarrantsMember us-gaap:MeasurementInputExercisePriceMember 2025-01-01 2025-12-31 0001652958 EDGM:ConversionOptionMember 2025-12-31 0001652958 EDGM:WarrantsMember 2025-12-31 iso4217:USD shares iso4217:USD shares pure EDGM:Integer false --12-31 2026 Q2 0001652958 1 1 2 1 10-Q true 2026-06-30 false 000-55647 EDGEMODE, INC. NV 47-4046237 110 E. Broward Blvd.  Suite 1700 Ft. Lauderdale FL 33301 707 687-9093 Yes Yes Non-accelerated Filer true false false 4791424217 16710 248367 18974 18791 35684 267158 51 51 0 513827 488049 495000 85454 0 939327 0 1548565 1276036 1425095 1175090 1327489 455989 1768174 915137 35000 35000 1774445 1774445 303613 75951 3824915 15424561 90693 0 10549424 19856173 0 227662 10549424 20083835 0.001 0.001 5000000 5000000 0 0 2 2 0.001 0.001 2 2 2 2 1 1 7000000000 7000000000 0.001 0.001 4279853240 4279853240 2998158602 2998158602 4279853 2998159 60792745 43308300 -73891336 -65114259 -8818737 -18807799 -182122 0 -9000859 -18807799 1548565 1276036 1322122 3262408 2615518 25377515 0 0 12949436 0 0 0 0 34 1322122 3262408 15564954 25377549 -1322122 -3262408 -15564954 -25377549 1277679 20377 2479112 31564 -705807 -396443 9018915 857804 0 -148053 0 -148053 472 0 948 0 -1983014 -564873 6540751 678187 -3305136 -3827281 -9024203 -24699362 0 0 0 0 -3305136 -3827281 -9024203 -24699362 -177964 -0 -247126 -0 -3127172 -3827281 -8777077 -24699362 -0.00 -0.00 -0.00 -0.02 -0.00 -0.00 -0.00 -0.02 3757514468 2119785143 3436805507 1260012814 3974314468 2119785143 3653605507 1260012814 2 1 2998158602 2998159 43308300 -65114259 -18807799 60397351 60397 715480 775877 1050000 1050 22395 23445 5991210 5991 34009 40000 16500000 16500 253000 269500 400000000 400000 -400000 63912296 63912 -63912 58215 58215 2565487 2565487 12949436 12949436 -5649905 -69162 -5719067 2 1 3546009459 3546009 59442410 -70764164 -69162 -7844906 15384615 15385 53922 69307 133479310 133479 26696 160175 574979856 574980 9095 584075 10000000 10000 27000 37000 1187834 1187834 45788 45788 65004 65004 -3127172 -177964 -3305136 2 1 4279853240 4279853 60792745 -73891336 -182122 -9000859 0 390687459 390687 35371266 -40484968 -4723015 21679711 21679711 -20872081 -20872081 0 390687459 390687 57050977 -61357059 -3915385 38510911 38511 261489 300000 513320326 513320 1026641 1539961 1260246354 1260246 1890370 3150616 92119909 92120 548338 640508 7500000 7500 18750 26250 100000 100000 2567176 2567176 -3827281 -3827281 0 2302384959 2302384 63463791 -65184330 581845 -9024203 -24699362 752794 0 1157022 0 284465 0 160175 0 13255936 24273137 -0 -34 9018915 857804 34507 0 0 101758 -0 -148053 45788 0 183 -78465 299742 176757 871500 431861 0 303614 -1181372 -43487 -0 183000 425500 47915 -425500 -230915 852135 0 0 300000 700500 0 177420 -0 -0 9900 1375215 290100 -231657 15698 248367 103 16710 15801 0 0 0 0 1870124 640508 2565487 23445 0 73782 0 6951 0 63912 0 400000 0 119961 0 65004 0 0 3150616 0 1750000 0 1539961 0 100000 <p id="xdx_809_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zyzLnfO0Ot4f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 1 – <span id="xdx_826_zyVWNByc03r5">Company Overview</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Edgemode, Inc. (“we,” “our,” the “Company”) was incorporated in Nevada on January 21, 2011. Since its incorporation, the Company has attempted to become involved in a number of prior business ventures, all of which were unsuccessful and which it has abandoned. Our subsidiary, Edgemode Wyoming, was incorporated in the State of Wyoming in March 2020. Between 2021 and 2023, we attempted to become a key figure in Bitcoin mining but lacked the necessary funding to finance the purchase of Bitcoin mining hardware and hosting contracts. As a result, since late 2023 and throughout 2024, our business activities primarily consisted of identifying and evaluating suitable acquisition transaction candidates, which led to a transition from cryptocurrency mining to digital infrastructure colocation services and high-performance computing (“HPC”) hosting.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective April 7, 2025, Edgemode, Synthesis Analytics Production Ltd. (“SAPL”) and Adler Capital Limited (“ACL”) closed on the Share Exchange dated April 7, 2025 (the “Share Exchange”). In accordance with the Share Exchange, SAPL agreed to transfer 100% of SAPL’s outstanding capital stock to Edgemode in exchange for 1,260,246,354 shares of Edgemode common stock, par value $0.001 per share, which represented approximately 55% of the Company’s outstanding common stock at the Effective Time. The Company accounted for the acquisition as an asset acquisition under ASC 805 as SAPL did not meet the definition of a business as it did not contain a full set of integrated inputs and outputs at the time of closing.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following the closing of the Share Exchange, Edgemode, through SAPL, its wholly owned subsidiary, intended to design, build, and operate digital infrastructure HPC with the goal of becoming a leading provider of digital colocation services. Pursuant to a letter dated December 8, 2025, and a complaint filed by the Company in the United States District Court for the Southern District of Florida, the Company intends to seek rescission of the Share Exchange and rescind the shares of Company common stock issued to ACL pursuant to the Share Exchange. The Company has sent notice to Dr. Adler for the termination of the option to purchase common stock issued to Dr. Adler under the Employment Agreement and the termination of such agreement for “cause” as defined under the agreement. Among other material breaches, without limitation, the Company has discovered that the real property and material assets of SAPL were encumbered at the time of the closing of the Share Exchange and remain encumbered and subject to liens.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 15, 2025, the Company and Blackberry AIF (“BAIF”) entered into a memorandum of understanding (the “MOU”) for the purposes of organizing DC Estate Solutions Cayman Limited, a Cayman Island entity (“DC Estate Solutions” or the “Joint Venture Company”) which was organized by the Company on October 23, 2025. On November 6, 2025, DC Estate Solutions and BAIF entered into a share purchase agreement (the “SPV SPA”). DC Estate Solutions was initially owned and controlled 75% by the Company and 25% by BAIF. The principal of BAIF is Jose Mora. DC Estate Solutions has acquired five property leases, which were previously assigned to and held by BAIF, consisting of 100 hectares of land each located in the Spain cities of Malpica, Caceres, Vianos, Cordoba and Torrecampo (the “Spain Leases”). The Spain Leases are held by wholly owned subsidiaries of DC Estate Solutions. The Spain Leases are for an average term of 35 years at an initial total average cost of $96,000 per month for all sites. As a condition of each lease, the payments are subject to meeting certain milestones, such as obtaining favorable urban compatibility reports and connection points. Under the terms of the Spain Leases, the Company will pay approximately $<span id="xdx_904_eus-gaap--ContractualObligation_iI_c20251015__us-gaap--TransactionTypeAxis__custom--SpainLeasesMember_ze8acriTeRs5" title="Contractual obligation">15,000</span> to the owners of the Cordoba site in 2026. No further payments are expected in 2026. Subsequent to December 31, 2025, and effective January 22, 2026, the Company entered into a Joint Venture Agreement (the “JVA”) by and among the Company, BAIF and DC Estate Solutions, which (i) amends and restates the MOU and (ii) supplements the SPV SPA. Pursuant to the SPV SPA, DC Estate Solutions acquired the equity interests of five special purpose vehicles (the “SPVs”): (i) DC Estate Córdoba SL 300MW, (ii) DC Estate Cáceres SL 300 MW, (iii) DC Estate Vianos SL 300 MW, (iv) DC Estate Malpica SL 300 MW and (v) DC Estate Torrecampo SL 300 MW. As a result of the acquisition of the SPVs, DC Estate Solutions also acquired the Spain Leases.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the JVA, DC Estate Solutions shall be owned <span id="xdx_90D_ecustom--MajorityInterestInJointVentures_iI_pip0_dp_c20251015__srt--OwnershipAxis__custom--DCEstatesSolutionsMember_zaEIRk1nDqZe" title="Transfer percentage">50.1</span>% by the Company and <span id="xdx_90A_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pip0_dp_c20251015__srt--OwnershipAxis__custom--BAIFMember_zSkeYZ5b7rK8" title="Transfer percentage">49.9</span>% by BAIF. The purpose of the JVA is to manage and coordinate the development of HPC data center (the “Data Centers”) sites on the properties governed by the Spain Leases. Substantially, all material decisions of the JVA and Joint Venture Company shall require the unanimous consent of the Company and BAIF. Under the JVA, the Company agreed to fund DC Estate Solutions with $3,500,000 USD as follows: (i) $250,000 USD, which was previously paid upon the execution of the MOU, (ii) $250,000 USD, which was previously paid upon execution of the SPV SPA, (iii) $375,000 USD paid on the effectiveness of a notarial public deed in Spain in connection with the transfer of the SPVs to the JVA on the Effective Date, and (iv) $2,625,000 USD payable in monthly installments of $125,000 USD commencing on March 1, 2026. The funds shall be distributed by DC Estate Solutions to BAIF. The Company also agreed to grant to BAIF, or its assignee, a non-qualified option to purchase up to 250,000,000 shares of the Company’s common stock (the “First Mora Option”) at an exercise price of $0.02 per share. The First Mora Option is fully vested and exercisable upon the grant date and terminates on the earlier of (i) five years following the date of the First Mora Option or (ii) the termination of the JVA.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, effective January 27, 2026, the Company, BAIF and DC Estate Solutions entered into an addendum to the JVA (the “Addendum”) to account for the development of additional data centers in (i) Villasequilla, Spain 600 MW, (ii) Tomelloso, Spain 450 MW and (iii) Tocumen, Panama 1000 MW. The Villasequilla and Tomelloso data centers shall each be owned by Spanish special purpose vehicles, DC Villasequilla SL and DC Tomelloso SL, respectively, and shall subsequently be assigned to DC Estate Solutions. The Tocumen data center shall be owned by a Panamanian special purpose vehicle, DC Tocumen SA, which shall subsequently be assigned to DC Estate Solutions. The Company, in addition to the already agreed upon $125,000 USD monthly payments, agreed to fund the development of the additional Data Centers by paying a minimum of $2,400,000 USD payable in monthly installments of $100,000 USD to DC Estate Solutions commencing on May 1, 2026 for a minimum of 24 months, thereby increasing the minimum BAIF Funding amount to a total of $11,150,000 USD. The funds shall be distributed by DC Estate Solutions to BAIF. The Company also agreed to grant to BAIF, or its assignee, the Second Mora Option to acquire 150,000,000 shares of the Company’s common stock at an exercise price of $0.02 per share. The Second Mora Option is fully vested and exercisable as of the grant date and terminates on the earlier of (i) five years following the date of the Second Mora Option or (ii) the termination of the JVA.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 23, 2026, the Company, BAIF and DC Estate Solutions entered into a second addendum (the “Second Addendum”) to the JVA. Pursuant to the Second Addendum, the parties agreed to: (1) increase the capacity of the Spain-based data centers to 4,350 MW and (2) exchange the stock options to purchase an aggregate of 400,000,000 shares of common stock of the Company issued to BAIF or its assignees issued under the JVA for 400,000,000 shares of the Company’s restricted common stock to BAIF or its assignees with such shares being fully paid and non-assessable on the date of execution of the Second Addendum.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 15000 0.501 0.499 <p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zg4xYk9bduXh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 2 – <span id="xdx_824_z3S8q2BO0NRe">Summary of Significant Accounting Policies</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zIHUVEkU0fte" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_862_zheYzqU22g4d">Basis of presentation</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”), and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as filed with the SEC. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for our interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements that would substantially duplicate the disclosure contained in the audited financial statements for fiscal 2025, as reported in the Form 10-K for the fiscal year ended December 31, 2025 of the Company, have been omitted.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_846_eus-gaap--ConsolidationPolicyTextBlock_z984HUyAHsUl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_86E_zEF7yFwVaWwg">Principals of consolidation</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying consolidated financial statements include the accounts of Edgemode, Inc., the accounts of its 100% owned subsidiaries, EdgeMode Wyoming, Edgemode Mine Co UK Limited, and Synthesis Analytics Production Ltd. All intercompany transactions and balances have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_843_eus-gaap--ConsolidationVariableInterestEntityPolicy_zxKRNHNrF3L3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_867_zZ64M4qCBjNb">Variable Interest Entities</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company evaluates its ownership interests and other arrangements involving legal entities to determine whether the entities are subject to consolidation under the variable interest entity (“VIE”) model in accordance with ASC 810, <i>Consolidation</i>. A legal entity is determined to be a VIE when, by design, either:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The entity lacks sufficient equity to finance its activities without additional subordinated financial support;</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The equity holders, as a group, lack the characteristics of a controlling financial interest; or</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The voting rights of the equity holders are not proportionate to their economic interests and substantially all activities are conducted on behalf of an investor with disproportionately few voting rights.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company consolidates a VIE when it is determined to be the primary beneficiary of the entity. The Company is considered the primary beneficiary when it has:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The power to direct the activities that most significantly impact the VIE’s economic performance; and</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In determining whether the Company is the primary beneficiary, management evaluates qualitative and quantitative factors, including governance rights, decision-making authority, contractual arrangements, capital structure, sharing of economic risks and rewards, and related-party relationships.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company continuously reassesses whether it is the primary beneficiary of a VIE as facts and circumstances change.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assets and liabilities of consolidated VIEs are presented separately on the consolidated balance sheets where material. The interests of third parties in consolidated VIEs are presented as noncontrolling interests. Intercompany balances and transactions are eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p id="xdx_844_eus-gaap--UseOfEstimates_zSP6WoOxJ2rf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_86D_zlAouSGn91h8">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Actual results could materially differ from these estimates. It is reasonably possible that changes in estimates will occur in the near term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zFxEwlbvHDB9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_864_zJyclwwsOGma">Basic and Diluted Loss Per Share</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The basic net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed by dividing the net loss adjusted on an “as if converted” basis, by the weighted average number of common shares outstanding plus potential dilutive securities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the effect of potential dilutive issuances for the three and six months ended June 30, 2026 and 2025:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zfjD4G7ENqh3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details - Potential dilutive issuances)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BD_zwi9Sd2QWY85" style="display: none">Schedule of potential dilutive issuances</span></td><td style="padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_49B_20260401__20260630_zxeADPDwbD64" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_49A_20250401__20250630_z3UmT7SIagd6" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_496_20260101__20260630_z1MKFXkcDeRf" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_49B_20250101__20250630_zuju1BUmj0N3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six Months Ended</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2025</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2025</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr id="xdx_40F_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zd5xIzMrQKR8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; width: 40%; text-align: left">Net income (loss) attributable to common stockholders</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(3,040,391</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(3,927,281</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(8,690,296</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(24,699,362</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_406_ecustom--IncrementalCommonSharesAttributableToWarrantsAndOptions_d0_z3iDMXWsADn5" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Derivative gain associated with warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,151,120</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(9,094,691</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_zCtiSOC2VHI1" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Net income (loss) for dilutive calculation</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,191,511</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3,927,281</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(17,784,987</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(24,699,362</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zJeYqSrhbE38" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt">Weighted average shares outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,757,514,468</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,119,785,143</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,436,805,507</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,260,012,814</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_d0_zRI1Td7pG6L2" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Dilutive effect of common stock warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">216,800,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">216,800,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zb5ObTUa6TVi" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt"><b style="display: none">Total diluted shares</b></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">3,974,314,468</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">2,119,785,143</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">3,653,605,507</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,260,012,814</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zJmz72cEmzt8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three and six months ended June 30, 2026, potential dilutive securities of <span id="xdx_90D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260401__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zv0DMRdx5vul" title="Antidilutive shares"><span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zOqtbVC5QAsc" title="Antidilutive shares">1,298,475,414</span></span> shares issuable upon exercise of options, and <span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260401__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zwJIAnyUCQU4" title="Antidilutive shares"><span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zvAkUr5wFXpi" title="Antidilutive shares">901,421,462</span></span> shares issuable upon conversion of debt, had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three and six months ended June 30, 2025, potential dilutive securities of <span id="xdx_902_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250401__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zPX0fli2RJ1c" title="Antidilutive shares"><span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_z31u907BeeN" title="Antidilutive shares">1,427,057,202</span></span> shares issuable upon exercise of options, <span id="xdx_90B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250401__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zPGtcTOFNIoc" title="Antidilutive shares"><span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zSmBYsWakp71" title="Antidilutive shares">9,530,000</span></span> shares issuable upon exercise of warrants, and <span id="xdx_90D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250401__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zwTtac1Tplek" title="Antidilutive shares"><span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zPBiBiDDXjil" title="Antidilutive shares">105,355,270</span></span> shares issuable upon conversion of debt, had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zqdINYEmqW29" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_868_zRzL1lnnCiV1">Segment Reporting</span> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company manages its operations as a single segment for the purpose of assessing performance and making operating decisions. The Company’s Chief Operating Decision Maker (“CODM”) is its executive management committee. The CODM allocates resources and evaluates the performance of the Company using information about net income from operations. All significant operating decisions are based upon an analysis of the Company as <span id="xdx_909_eus-gaap--NumberOfOperatingSegments_dxL_uInteger_c20260101__20260630_zMVfKIW9Ug1a" title="Number of operating segments::XDX::1"><span id="xdx_908_eus-gaap--NumberOfReportableSegments_dxL_uInteger_c20260101__20260630_zrpKIGzfYlnf" title="Number of reportable segments::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl0817"><span style="-sec-ix-hidden: xdx2ixbrl0819">one</span></span></span></span> operating segment, which is the same as its reporting segment. The Company will continue to evaluate for segments as it expands its operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p id="xdx_841_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z81ASiCRyhhc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_86A_zcL4jEe5JXC7">Fair Value Measurements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally accepted accounting principles define fair value as the price that would be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price) and such principles also establish a fair value hierarchy that prioritizes the inputs used to measure fair value using the following definitions (from highest to lowest priority):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> </td> <td style="width: 0.25in; text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. </span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol; font-size: 10pt">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 – Observable inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data by correlation or other means.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol; font-size: 10pt">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 – Prices or valuation techniques requiring inputs that are both significant to the fair value measurement and unobservable.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following fair value hierarchy tables present information about the Company’s liabilities measured at fair value on a recurring basis:</p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zlJaCXSlcCj7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BE_z55cwyZ6Dh54" style="display: none">Schedule of liabilities measured at fair value</span></td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">Fair Value Measurements at June 30, 2026</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%; font-weight: bold">Liabilities:</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Derivative liabilities</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DerivativeLiabilities_iI_d0_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zLjaM8jsJejl" style="text-align: right" title="Derivative liabilities">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DerivativeLiabilitiesCurrent_iI_d0_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zoHgk3jDiwM3" style="text-align: right" title="Derivative liabilities">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z0EPFeW1EZaf" style="text-align: right" title="Derivative liabilities">3,824,915</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">Fair Value Measurements at December 31, 2025</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Liabilities:</td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%; text-align: left">Derivative liabilities</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--DerivativeLiabilities_iI_d0_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zUhey05ah5Ae" style="width: 13%; text-align: right" title="Derivative liabilities">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--DerivativeLiabilitiesCurrent_iI_d0_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zNbUvj6fBbJl" style="width: 13%; text-align: right" title="Derivative liabilities">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYpcX4Ic3pqk" style="width: 13%; text-align: right" title="Derivative liabilities">15,424,561</td><td style="width: 1%; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zrPTs9no8KFh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had no assets valued using level 1, level 2, or level 3 inputs as of June 30, 2026 or December 31, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p id="xdx_849_eus-gaap--DerivativesPolicyTextBlock_z09MAwoRzF9h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86C_zpVbTpcgjPw3">Derivative Financial Instruments</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Derivatives are measured at their fair value on the balance sheet. In determining the appropriate fair value, the Company uses a binomial calculator model. Changes in fair value are recorded in the consolidated statements of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p id="xdx_841_eus-gaap--IncomeTaxPolicyTextBlock_zSU4GRSFoMSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_862_zNxVCyVUQwte">Income Taxes</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Income taxes are provided for the tax effects of transactions reporting in the financial statements and consist of taxes currently due plus deferred taxes related primarily to differences between the basis of receivables, inventory, property and equipment, intangible assets, and accrued expenses for financial and income tax reporting. The deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Any deferred tax items of the Company have been fully valued based on the determination of the Company that the utilization of any deferred tax assets is uncertain.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company complies with FASB ASC 740 for accounting for uncertainty in income taxes recognized in a company’s financial statements, which prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. FASB ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s financial statements. The Company believes that its income tax positions would be sustained on audit and does not anticipate any adjustments that would result in a material change to its financial position.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--RevenueRecognitionPolicyTextBlock_zYKNerkmZ358" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_865_zUykP41tPiI7">Revenue Recognition</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We recognize revenue in accordance with ASC 606, Revenue from Contracts with Customers. This standard provides a single comprehensive model to be used in the accounting for revenue arising from contracts with customers and supersedes current revenue recognition guidance, including industry-specific guidance. The standard’s stated core principle is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve this core principle, ASC 606 includes provisions within a five-step model that includes identifying the contract with a customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations, and recognizing revenue when, or as, an entity satisfies a performance obligation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is currently developing certain leased properties for the future development of high-performance data centers. The Company anticipates selling the leased properties once they reach a ready to build status or lease the properties to customers after the high-performance data centers are built. The Company has <span id="xdx_904_eus-gaap--Revenues_do_c20260101__20260630_zBCmcjV8VKAd">no</span>t yet generated any revenue as of June 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_845_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zIFTGWmJl7ee" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_86D_zvYwpeCAlfwf">Stock-Based Compensation</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for equity instruments issued to employees in accordance with the provisions of ASC 718 Stock Compensation (ASC 718) and Equity-Based Payments to Non-employees pursuant to ASC 2018-07 (ASC 2018-07). All transactions in which the consideration provided in exchange for the purchase of goods or services consists of the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty’s performance is complete or the date at which a commitment for performance by the counterparty to earn the equity instruments is reached because of sufficiently large disincentives for nonperformance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p id="xdx_84C_eus-gaap--AdvertisingCostsPolicyTextBlock_zrYMT9QRTBYg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_868_zcTz0CsULK1c">Advertising</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company expenses advertising costs as they are incurred. The Company had <span id="xdx_905_eus-gaap--AdvertisingExpense_do_c20260101__20260630_zuQnH5WN2Olk" title="Advertising costs"><span id="xdx_904_eus-gaap--AdvertisingExpense_do_c20250101__20250630_zfehT5T1SrWk" title="Advertising costs">no</span></span> advertising costs for the six months ended June 30, 2026 and 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--DeferredChargesPolicyTextBlock_zFNjiBVgRya9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_86D_z9sBX48iDax5">Deferred Offering Costs</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had capitalized qualified direct costs related to its efforts to raise capital through a sale of its common stock in a private offering related to the issuance of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20251231__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateOfferingMember_zFm9cVMV1n68" title="Stock issued new, shares">25,000,000</span> shares of common stock with a value of $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20251231__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateOfferingMember_zPChV94Wilt5" title="Stock issued new, value">495,000</span> as of December 31, 2025, and will be amortized ratably upon sales under the offering, and upon completion, they will be reclassified to additional paid-in capital as a reduction of the offering proceeds. If the Company terminates the offering or there is a significant delay, all of the deferred offering costs will be immediately written off to operating expenses. During the six months ended June 30, 2026, the Company amortized $<span id="xdx_905_eus-gaap--AmortizationOfDeferredCharges_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateOfferingMember_zKcT2ln4EZdg" title="Amortization of deferred offering costs">6,951</span> of costs against the offering proceeds and has a remaining $<span id="xdx_907_eus-gaap--DeferredOfferingCosts_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateOfferingMember_zlPLQTryd5h4" title="Deferred offering costs">488,049</span> of costs expected to be amortized. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z11pjrfgqyd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_869_zM9lpNV7mlwc">Recent Accounting Pronouncements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2024, the FASB issued <span style="text-decoration: underline">ASU 2024-03</span>, <i>Disaggregation of Income Statement Expenses</i>, and in January 2025, the FASB issued <span style="text-decoration: underline">ASU 2025-01</span>, <i>Clarifying the Effective Date</i> (“ASU 2025-01”). The amendments are intended to enhance disclosures regarding an entity’s costs and expenses by requiring additional disaggregated information disclosures about certain income statement expense line items. The amendments, as clarified by ASU 2025-01, are effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the effect of this pronouncement on its disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zIHUVEkU0fte" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_862_zheYzqU22g4d">Basis of presentation</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”), and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as filed with the SEC. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for our interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements that would substantially duplicate the disclosure contained in the audited financial statements for fiscal 2025, as reported in the Form 10-K for the fiscal year ended December 31, 2025 of the Company, have been omitted.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_846_eus-gaap--ConsolidationPolicyTextBlock_z984HUyAHsUl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_86E_zEF7yFwVaWwg">Principals of consolidation</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying consolidated financial statements include the accounts of Edgemode, Inc., the accounts of its 100% owned subsidiaries, EdgeMode Wyoming, Edgemode Mine Co UK Limited, and Synthesis Analytics Production Ltd. All intercompany transactions and balances have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_843_eus-gaap--ConsolidationVariableInterestEntityPolicy_zxKRNHNrF3L3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_867_zZ64M4qCBjNb">Variable Interest Entities</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company evaluates its ownership interests and other arrangements involving legal entities to determine whether the entities are subject to consolidation under the variable interest entity (“VIE”) model in accordance with ASC 810, <i>Consolidation</i>. A legal entity is determined to be a VIE when, by design, either:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The entity lacks sufficient equity to finance its activities without additional subordinated financial support;</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The equity holders, as a group, lack the characteristics of a controlling financial interest; or</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The voting rights of the equity holders are not proportionate to their economic interests and substantially all activities are conducted on behalf of an investor with disproportionately few voting rights.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company consolidates a VIE when it is determined to be the primary beneficiary of the entity. The Company is considered the primary beneficiary when it has:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The power to direct the activities that most significantly impact the VIE’s economic performance; and</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In determining whether the Company is the primary beneficiary, management evaluates qualitative and quantitative factors, including governance rights, decision-making authority, contractual arrangements, capital structure, sharing of economic risks and rewards, and related-party relationships.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company continuously reassesses whether it is the primary beneficiary of a VIE as facts and circumstances change.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assets and liabilities of consolidated VIEs are presented separately on the consolidated balance sheets where material. The interests of third parties in consolidated VIEs are presented as noncontrolling interests. Intercompany balances and transactions are eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p id="xdx_844_eus-gaap--UseOfEstimates_zSP6WoOxJ2rf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_86D_zlAouSGn91h8">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Actual results could materially differ from these estimates. It is reasonably possible that changes in estimates will occur in the near term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zFxEwlbvHDB9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_864_zJyclwwsOGma">Basic and Diluted Loss Per Share</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The basic net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed by dividing the net loss adjusted on an “as if converted” basis, by the weighted average number of common shares outstanding plus potential dilutive securities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the effect of potential dilutive issuances for the three and six months ended June 30, 2026 and 2025:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zfjD4G7ENqh3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details - Potential dilutive issuances)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BD_zwi9Sd2QWY85" style="display: none">Schedule of potential dilutive issuances</span></td><td style="padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_49B_20260401__20260630_zxeADPDwbD64" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_49A_20250401__20250630_z3UmT7SIagd6" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_496_20260101__20260630_z1MKFXkcDeRf" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_49B_20250101__20250630_zuju1BUmj0N3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six Months Ended</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2025</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2025</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr id="xdx_40F_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zd5xIzMrQKR8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; width: 40%; text-align: left">Net income (loss) attributable to common stockholders</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(3,040,391</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(3,927,281</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(8,690,296</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(24,699,362</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_406_ecustom--IncrementalCommonSharesAttributableToWarrantsAndOptions_d0_z3iDMXWsADn5" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Derivative gain associated with warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,151,120</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(9,094,691</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_zCtiSOC2VHI1" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Net income (loss) for dilutive calculation</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,191,511</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3,927,281</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(17,784,987</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(24,699,362</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zJeYqSrhbE38" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt">Weighted average shares outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,757,514,468</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,119,785,143</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,436,805,507</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,260,012,814</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_d0_zRI1Td7pG6L2" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Dilutive effect of common stock warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">216,800,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">216,800,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zb5ObTUa6TVi" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt"><b style="display: none">Total diluted shares</b></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">3,974,314,468</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">2,119,785,143</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">3,653,605,507</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,260,012,814</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zJmz72cEmzt8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three and six months ended June 30, 2026, potential dilutive securities of <span id="xdx_90D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260401__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zv0DMRdx5vul" title="Antidilutive shares"><span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zOqtbVC5QAsc" title="Antidilutive shares">1,298,475,414</span></span> shares issuable upon exercise of options, and <span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260401__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zwJIAnyUCQU4" title="Antidilutive shares"><span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zvAkUr5wFXpi" title="Antidilutive shares">901,421,462</span></span> shares issuable upon conversion of debt, had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three and six months ended June 30, 2025, potential dilutive securities of <span id="xdx_902_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250401__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zPX0fli2RJ1c" title="Antidilutive shares"><span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_z31u907BeeN" title="Antidilutive shares">1,427,057,202</span></span> shares issuable upon exercise of options, <span id="xdx_90B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250401__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zPGtcTOFNIoc" title="Antidilutive shares"><span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zSmBYsWakp71" title="Antidilutive shares">9,530,000</span></span> shares issuable upon exercise of warrants, and <span id="xdx_90D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250401__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zwTtac1Tplek" title="Antidilutive shares"><span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zPBiBiDDXjil" title="Antidilutive shares">105,355,270</span></span> shares issuable upon conversion of debt, had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zfjD4G7ENqh3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details - Potential dilutive issuances)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BD_zwi9Sd2QWY85" style="display: none">Schedule of potential dilutive issuances</span></td><td style="padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_49B_20260401__20260630_zxeADPDwbD64" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_49A_20250401__20250630_z3UmT7SIagd6" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_496_20260101__20260630_z1MKFXkcDeRf" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_49B_20250101__20250630_zuju1BUmj0N3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six Months Ended</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2025</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2025</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr id="xdx_40F_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zd5xIzMrQKR8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; width: 40%; text-align: left">Net income (loss) attributable to common stockholders</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(3,040,391</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(3,927,281</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(8,690,296</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(24,699,362</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_406_ecustom--IncrementalCommonSharesAttributableToWarrantsAndOptions_d0_z3iDMXWsADn5" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Derivative gain associated with warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,151,120</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(9,094,691</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_zCtiSOC2VHI1" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Net income (loss) for dilutive calculation</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,191,511</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3,927,281</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(17,784,987</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(24,699,362</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zJeYqSrhbE38" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt">Weighted average shares outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,757,514,468</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,119,785,143</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,436,805,507</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,260,012,814</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_d0_zRI1Td7pG6L2" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Dilutive effect of common stock warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">216,800,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">216,800,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zb5ObTUa6TVi" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt"><b style="display: none">Total diluted shares</b></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">3,974,314,468</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">2,119,785,143</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">3,653,605,507</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,260,012,814</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> -3040391 -3927281 -8690296 -24699362 -1151120 0 -9094691 0 -4191511 -3927281 -17784987 -24699362 3757514468 2119785143 3436805507 1260012814 216800000 0 216800000 0 3974314468 2119785143 3653605507 1260012814 1298475414 1298475414 901421462 901421462 1427057202 1427057202 9530000 9530000 105355270 105355270 <p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zqdINYEmqW29" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_868_zRzL1lnnCiV1">Segment Reporting</span> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company manages its operations as a single segment for the purpose of assessing performance and making operating decisions. The Company’s Chief Operating Decision Maker (“CODM”) is its executive management committee. The CODM allocates resources and evaluates the performance of the Company using information about net income from operations. All significant operating decisions are based upon an analysis of the Company as <span id="xdx_909_eus-gaap--NumberOfOperatingSegments_dxL_uInteger_c20260101__20260630_zMVfKIW9Ug1a" title="Number of operating segments::XDX::1"><span id="xdx_908_eus-gaap--NumberOfReportableSegments_dxL_uInteger_c20260101__20260630_zrpKIGzfYlnf" title="Number of reportable segments::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl0817"><span style="-sec-ix-hidden: xdx2ixbrl0819">one</span></span></span></span> operating segment, which is the same as its reporting segment. The Company will continue to evaluate for segments as it expands its operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p id="xdx_841_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z81ASiCRyhhc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_86A_zcL4jEe5JXC7">Fair Value Measurements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally accepted accounting principles define fair value as the price that would be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price) and such principles also establish a fair value hierarchy that prioritizes the inputs used to measure fair value using the following definitions (from highest to lowest priority):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> </td> <td style="width: 0.25in; text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. </span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol; font-size: 10pt">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 – Observable inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data by correlation or other means.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol; font-size: 10pt">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 – Prices or valuation techniques requiring inputs that are both significant to the fair value measurement and unobservable.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following fair value hierarchy tables present information about the Company’s liabilities measured at fair value on a recurring basis:</p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zlJaCXSlcCj7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BE_z55cwyZ6Dh54" style="display: none">Schedule of liabilities measured at fair value</span></td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">Fair Value Measurements at June 30, 2026</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%; font-weight: bold">Liabilities:</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Derivative liabilities</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DerivativeLiabilities_iI_d0_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zLjaM8jsJejl" style="text-align: right" title="Derivative liabilities">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DerivativeLiabilitiesCurrent_iI_d0_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zoHgk3jDiwM3" style="text-align: right" title="Derivative liabilities">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z0EPFeW1EZaf" style="text-align: right" title="Derivative liabilities">3,824,915</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">Fair Value Measurements at December 31, 2025</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Liabilities:</td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%; text-align: left">Derivative liabilities</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--DerivativeLiabilities_iI_d0_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zUhey05ah5Ae" style="width: 13%; text-align: right" title="Derivative liabilities">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--DerivativeLiabilitiesCurrent_iI_d0_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zNbUvj6fBbJl" style="width: 13%; text-align: right" title="Derivative liabilities">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYpcX4Ic3pqk" style="width: 13%; text-align: right" title="Derivative liabilities">15,424,561</td><td style="width: 1%; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zrPTs9no8KFh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had no assets valued using level 1, level 2, or level 3 inputs as of June 30, 2026 or December 31, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zlJaCXSlcCj7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BE_z55cwyZ6Dh54" style="display: none">Schedule of liabilities measured at fair value</span></td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">Fair Value Measurements at June 30, 2026</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%; font-weight: bold">Liabilities:</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Derivative liabilities</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DerivativeLiabilities_iI_d0_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zLjaM8jsJejl" style="text-align: right" title="Derivative liabilities">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DerivativeLiabilitiesCurrent_iI_d0_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zoHgk3jDiwM3" style="text-align: right" title="Derivative liabilities">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z0EPFeW1EZaf" style="text-align: right" title="Derivative liabilities">3,824,915</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">Fair Value Measurements at December 31, 2025</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Liabilities:</td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%; text-align: left">Derivative liabilities</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--DerivativeLiabilities_iI_d0_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zUhey05ah5Ae" style="width: 13%; text-align: right" title="Derivative liabilities">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--DerivativeLiabilitiesCurrent_iI_d0_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zNbUvj6fBbJl" style="width: 13%; text-align: right" title="Derivative liabilities">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYpcX4Ic3pqk" style="width: 13%; text-align: right" title="Derivative liabilities">15,424,561</td><td style="width: 1%; text-align: left"> </td></tr> </table> 0 0 3824915 0 0 15424561 <p id="xdx_849_eus-gaap--DerivativesPolicyTextBlock_z09MAwoRzF9h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86C_zpVbTpcgjPw3">Derivative Financial Instruments</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Derivatives are measured at their fair value on the balance sheet. In determining the appropriate fair value, the Company uses a binomial calculator model. Changes in fair value are recorded in the consolidated statements of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p id="xdx_841_eus-gaap--IncomeTaxPolicyTextBlock_zSU4GRSFoMSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_862_zNxVCyVUQwte">Income Taxes</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Income taxes are provided for the tax effects of transactions reporting in the financial statements and consist of taxes currently due plus deferred taxes related primarily to differences between the basis of receivables, inventory, property and equipment, intangible assets, and accrued expenses for financial and income tax reporting. The deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Any deferred tax items of the Company have been fully valued based on the determination of the Company that the utilization of any deferred tax assets is uncertain.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company complies with FASB ASC 740 for accounting for uncertainty in income taxes recognized in a company’s financial statements, which prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. FASB ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s financial statements. The Company believes that its income tax positions would be sustained on audit and does not anticipate any adjustments that would result in a material change to its financial position.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--RevenueRecognitionPolicyTextBlock_zYKNerkmZ358" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_865_zUykP41tPiI7">Revenue Recognition</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We recognize revenue in accordance with ASC 606, Revenue from Contracts with Customers. This standard provides a single comprehensive model to be used in the accounting for revenue arising from contracts with customers and supersedes current revenue recognition guidance, including industry-specific guidance. The standard’s stated core principle is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve this core principle, ASC 606 includes provisions within a five-step model that includes identifying the contract with a customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations, and recognizing revenue when, or as, an entity satisfies a performance obligation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is currently developing certain leased properties for the future development of high-performance data centers. The Company anticipates selling the leased properties once they reach a ready to build status or lease the properties to customers after the high-performance data centers are built. The Company has <span id="xdx_904_eus-gaap--Revenues_do_c20260101__20260630_zBCmcjV8VKAd">no</span>t yet generated any revenue as of June 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0 <p id="xdx_845_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zIFTGWmJl7ee" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_86D_zvYwpeCAlfwf">Stock-Based Compensation</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for equity instruments issued to employees in accordance with the provisions of ASC 718 Stock Compensation (ASC 718) and Equity-Based Payments to Non-employees pursuant to ASC 2018-07 (ASC 2018-07). All transactions in which the consideration provided in exchange for the purchase of goods or services consists of the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty’s performance is complete or the date at which a commitment for performance by the counterparty to earn the equity instruments is reached because of sufficiently large disincentives for nonperformance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p id="xdx_84C_eus-gaap--AdvertisingCostsPolicyTextBlock_zrYMT9QRTBYg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_868_zcTz0CsULK1c">Advertising</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company expenses advertising costs as they are incurred. The Company had <span id="xdx_905_eus-gaap--AdvertisingExpense_do_c20260101__20260630_zuQnH5WN2Olk" title="Advertising costs"><span id="xdx_904_eus-gaap--AdvertisingExpense_do_c20250101__20250630_zfehT5T1SrWk" title="Advertising costs">no</span></span> advertising costs for the six months ended June 30, 2026 and 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0 0 <p id="xdx_842_eus-gaap--DeferredChargesPolicyTextBlock_zFNjiBVgRya9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_86D_z9sBX48iDax5">Deferred Offering Costs</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had capitalized qualified direct costs related to its efforts to raise capital through a sale of its common stock in a private offering related to the issuance of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20251231__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateOfferingMember_zFm9cVMV1n68" title="Stock issued new, shares">25,000,000</span> shares of common stock with a value of $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20251231__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateOfferingMember_zPChV94Wilt5" title="Stock issued new, value">495,000</span> as of December 31, 2025, and will be amortized ratably upon sales under the offering, and upon completion, they will be reclassified to additional paid-in capital as a reduction of the offering proceeds. If the Company terminates the offering or there is a significant delay, all of the deferred offering costs will be immediately written off to operating expenses. During the six months ended June 30, 2026, the Company amortized $<span id="xdx_905_eus-gaap--AmortizationOfDeferredCharges_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateOfferingMember_zKcT2ln4EZdg" title="Amortization of deferred offering costs">6,951</span> of costs against the offering proceeds and has a remaining $<span id="xdx_907_eus-gaap--DeferredOfferingCosts_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateOfferingMember_zlPLQTryd5h4" title="Deferred offering costs">488,049</span> of costs expected to be amortized. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 25000000 495000 6951 488049 <p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z11pjrfgqyd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_869_zM9lpNV7mlwc">Recent Accounting Pronouncements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2024, the FASB issued <span style="text-decoration: underline">ASU 2024-03</span>, <i>Disaggregation of Income Statement Expenses</i>, and in January 2025, the FASB issued <span style="text-decoration: underline">ASU 2025-01</span>, <i>Clarifying the Effective Date</i> (“ASU 2025-01”). The amendments are intended to enhance disclosures regarding an entity’s costs and expenses by requiring additional disaggregated information disclosures about certain income statement expense line items. The amendments, as clarified by ASU 2025-01, are effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the effect of this pronouncement on its disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_80C_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zDwTDG9bSfx9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 3 – <span id="xdx_829_z39swZhMAPh">Going Concern</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These financial statements have been prepared in accordance with generally accepted accounting principles applicable to a going concern, which assumes that the Company will be able to meet its obligations and continue its operations for its next fiscal year. Realization values may be substantially different from carrying values as shown and these financial statements do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern. At June 30, 2026, the Company had not yet achieved profitable operations and expects to incur further losses as it has suspended its operations until such time, if any, that the Company receives adequate funding, all of which raise substantial doubt about the Company’s ability to continue as a going concern. See “Note 11 Subsequent Events.” The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has no formal plan in place to address this concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p id="xdx_809_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zjnuw9xIVJtc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 4 – <span id="xdx_820_zjCp0bZ5t9D8">Related Party Transactions</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 10, 2026, the board of directors of the Company (the “Board”) approved grants to each of Charles Faulkner and Simon Wajcenberg, the Chief Executive Officer and Chief Financial Officer of the Company, respectively, of options to purchase up to <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20260209__20260210__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zLiK0FhLdhOc" title="Options granted, shares"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20260209__20260210__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefFinancialOfficerMember_zxtDVrzGMh51">350,000,000</span></span> shares of the Company’s common stock at an exercise price $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20260209__20260210__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zEHhdEszSrsh" title="Exercise price"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20260209__20260210__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefFinancialOfficerMember_zOpduaHEZLKj" title="Exercise price">0.006</span></span> exercisable for a term of five years <span style="background-color: white">(the “Stock Options”)</span>. 50% of the shares underlying each Stock Option shall become vested and exercisable upon the closing of a purchase agreement between the Company, or the Company’s subsidiaries, and a solid oxide fuel cell supplier for a minimum power capacity of 100 MW, and the remaining <span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_dp_c20260209__20260210__srt--TitleOfIndividualAxis__custom--BoardMember_z7pKgYMqmBTk" title="Stock option percentage">50</span>% shall become vested and exercisable upon the closing of an AI data center site sale agreement between the Company, or the Company’s subsidiaries, and a buyer which is for a minimum capacity of 100 MW, as determined by the Company’s board of directors.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2026 and December 31, 2025, the Company owed the executive officers of the Company $<span id="xdx_90F_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ExecutiveOfficerMember_zpWWhACjnMpl" title="Accrued payroll for services performed">1,032,210</span> and $<span id="xdx_903_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ExecutiveOfficerMember_zmFRWMmu8m98" title="Accrued payroll for services performed">455,989</span> in accrued payroll for services performed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2026 and December 31, 2025, the Company owed the executive officers $<span id="xdx_904_ecustom--NotesPayableRelatedParties_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ExecutiveOfficerMember_z3xO6ykNLm7h" title="Notes payable, related parties"><span id="xdx_900_ecustom--NotesPayableRelatedParties_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ExecutiveOfficerMember_zhrTkydOMjn1" title="Notes payable, related parties">24,445</span></span>, respectively, for working capital advances. The advances are non-interest bearing and are due on demand.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective April 7, 2025, Edgemode, assumed a $<span id="xdx_904_ecustom--NotesPayableRelatedParties_iI_c20250407__srt--CounterpartyNameAxis__custom--MarvikenTwoAbMember_zk8CvlRrnVP1">1,750,000</span> promissory note issued by Marviken TWO AB dated December 4, 2024, in connection with the Share Exchange. The loan will bear interest at a rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20250407__srt--CounterpartyNameAxis__custom--MarvikenTwoAbMember_z0QbUzJWFdpl">5</span>% and has a maturity date of <span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_dd_c20250406__20250407__srt--CounterpartyNameAxis__custom--MarvikenTwoAbMember_zBrJLRd7kbrc">December 3, 2027</span>. As a result of the transaction whereby Dr. Adler became a related party, the loan is included in the balance of the Notes payable – related parties on the accompanying balance sheet. In addition, the Company has imputed interest expense on the note for the difference between market rates and stated rates which was recorded as a contribution to capital of $<span id="xdx_90D_ecustom--ImputedInterestContributedToCapital_c20260101__20260630_zjhhPCKlxkmh">45,788</span> for the six months ended June 30, 2026. The Company has since filed a lawsuit seeking rescission of the Share Exchange and, if successful in rescinding, the Company’s obligation under this promissory note may be terminated or otherwise affected. See Note 10 “<span style="text-decoration: underline">Commitments and Contingencies</span>.”</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 350000000 350000000 0.006 0.006 0.50 1032210 455989 24445 24445 1750000 0.05 2027-12-03 45788 <p id="xdx_80D_eus-gaap--EquityMethodInvestmentsDisclosureTextBlock_zuGe8nryQyl3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 5 – <span id="xdx_829_zu5UhsrTRpei">Joint Venture Investment</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 15, 2025, the Company and BAIF entered into the MOU for the purposes of organizing DC Estate Solutions Cayman Limited, a Cayman Island entity. Upon execution of the MOU, the Company paid BAIF $<span id="xdx_905_ecustom--UnsecuredAdvances_iI_c20251015__dei--LegalEntityAxis__custom--BAIFMember_z2p0EtcTtb3i" title="Unsecured advances">250,000</span> and the Company paid BAIF an additional $<span id="xdx_90A_ecustom--UnsecuredAdvances_iI_c20260222__dei--LegalEntityAxis__custom--BAIFMember_z38v05dCD1Mg" title="Unsecured advances">250,000</span> on the closing of the SPV SPA. In addition, the Company has paid an additional $<span id="xdx_905_ecustom--UnsecuredAdvances_iI_c20260630__dei--LegalEntityAxis__custom--BAIFMember_zRHgoe40isXj" title="Unsecured advances">13,827</span> on behalf of BAIF for various expenses incurred as part of the transaction. The advances are unsecured and bear no interest.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective January 22, 2026, the Company entered into the JVA by and among the Company, BAIF and DC Estate Solutions, which (i) amends and restates the MOU and (ii) supplements the SPV SPA. Pursuant to the SPV SPA, DC Estate Solutions acquired the equity interests of the five SPVs: (i) DC Estate Córdoba SL 300MW, (ii) DC Estate Cáceres SL 300 MW, (iii) DC Estate Vianos SL 300 MW, (iv) DC Estate Malpica SL 300 MW and (v) DC Estate Torrecampo SL 300 MW. As a result of the acquisition of the SPVs, DC Estate Solutions also acquired the Spain Leases.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the JVA, DC Estate Solutions shall be owned 50.1% by the Company and 49.9% by BAIF. The purpose of the JVA is to manage and coordinate the development of the Data Center sites on the properties governed by the Spain Leases. Substantially, all material decisions of the JVA and Joint Venture Company shall require the unanimous consent of the Company and BAIF. Under the JVA, the Company agreed to fund DC Estate Solutions with $3,500,000 USD as follows: (i) $250,000 USD, which was previously paid upon the execution of the MOU, (ii) $250,000 USD, which was previously paid upon execution of the SPV SPA, (iii) $375,000 USD paid on the effectiveness of a notarial public deed in Spain in connection with the transfer of the SPVs to the JVA on the Effective Date, and (iv) $2,625,000 USD payable in monthly installments of $125,000 USD commencing on March 1, 2026. The funds shall be distributed by DC Estate Solutions to BAIF. If the Company fails to make such payments, BAIF may foreclose on the pro rata amount of equity interests in the SPVs. In the event of any sale or lease of a Data Center, profits of DC Estate Solutions shall be shared equally by and between the Company and BAIF. In the event DC Estate Solutions develops the Data Centers and sells such Data Centers, BAIF will be entitled to a bonus as defined under the JVA.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also agreed to grant to BAIF, or its assignee, the First Mora Option to purchase up to 250,000,000 shares of the Company’s common stock at an exercise price of $0.02 per share. The First Mora Option is fully vested and exercisable upon the grant date and terminates on the earlier of (i) five years following the date of the First Mora Option or (ii) the termination of the JVA.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, effective January 27, 2026, the Company, BAIF and DC Estate Solutions entered into the Addendum to the JVA to account for the development of additional data centers in (i) Villasequilla, Spain 600 MW, (ii) Tomelloso, Spain 450 MW and (iii) Tocumen, Panama 1000 MW. The Villasequilla and Tomelloso data centers shall each be owned by Spanish special purpose vehicles, DC Villasequilla SL and DC Tomelloso SL, respectively, and shall subsequently be assigned to DC Estate Solutions. The Tocumen data center shall be owned by a Panamanian special purpose vehicle, DC Tocumen SA, which shall subsequently be assigned to DC Estate Solutions. The Company, in addition to the already agreed upon $125,000 USD monthly payments, agreed to fund the development of the additional Data Centers by paying a minimum of $2,400,000 USD payable in monthly installments of $100,000 USD to DC Estate Solutions commencing on May 1, 2026 for a minimum of 24 months, thereby increasing the minimum BAIF Funding amount to a total of $11,150,000 USD. The funds shall be distributed by DC Estate Solutions to BAIF. The Company also agreed to grant to BAIF, or its assignee, the Second Mora Option to acquire 150,000,000 shares of the Company’s common stock at an exercise price of $0.02 per share. The Second Mora Option is fully vested and exercisable as of the grant date and terminates on the earlier of (i) five years following the date of the Second Mora Option or (ii) the termination of the JVA.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 23, 2026, the Company, BAIF and DC Estate Solutions entered into a second addendum (the “Second Addendum”) to the JVA. Pursuant to the Second Addendum, the parties agreed to: (1) increase the capacity of the Spain-based data centers to 4,350 MW and (2) exchange the stock options to purchase an aggregate of 400,000,000 shares of common stock of the Company issued to BAIF or its assignees issued under the JVA for 400,000,000 shares of the Company’s restricted common stock to BAIF or its assignees with such shares being fully paid and non-assessable on the date of execution of the Second Addendum. The exchange resulted in a de minimis increase in fair value and as a result no additional expense was recognized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company consolidates DC Estates Solutions, as pursuant to the governing operating agreement, the Company has the power to direct the activities that most significantly impact DC Estates Solutions’ economic performance, as a result of its unconditional funding obligation. Accordingly, the Company determined that it controls DC Estates Solutions and consolidates the entity in its consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From the date of formation through June 30, 2026, the joint venture had no reportable operations. As of June 30, 2026, the balance sheet of the joint ventures consists of:</p> <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--JointVentureFormationTableTextBlock_zo3k5Ygv1pc6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Joint Venture Investment (Details - Balance sheet of joint ventures)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B0_zH7gxbWyuWbk" style="display: none">Schedule of balance sheet of joint ventures</span></td><td> </td> <td colspan="3" id="xdx_494_20260630__srt--CounterpartyNameAxis__custom--JointVenturesMember_z8D80cEc6gwa" style="text-align: center"> </td></tr> <tr id="xdx_40B_eus-gaap--ConstructionInProgressGross_iI_zRJjZNhYIkg8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: left">Construction in Progress</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">939,327</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zi5O9oF3w3ri" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Right of use assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">85,454</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--Assets_iI_zLfMtiioJZx4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Total Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,024,781</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zjrUrBJ4PHa9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Right of use liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">90,693</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--Liabilities_iI_zveO3qJbF5D4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total Liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">90,693</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zWvP2BqNeOgl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 250000 250000 13827 <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--JointVentureFormationTableTextBlock_zo3k5Ygv1pc6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Joint Venture Investment (Details - Balance sheet of joint ventures)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B0_zH7gxbWyuWbk" style="display: none">Schedule of balance sheet of joint ventures</span></td><td> </td> <td colspan="3" id="xdx_494_20260630__srt--CounterpartyNameAxis__custom--JointVenturesMember_z8D80cEc6gwa" style="text-align: center"> </td></tr> <tr id="xdx_40B_eus-gaap--ConstructionInProgressGross_iI_zRJjZNhYIkg8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: left">Construction in Progress</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">939,327</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zi5O9oF3w3ri" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Right of use assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">85,454</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--Assets_iI_zLfMtiioJZx4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Total Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,024,781</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zjrUrBJ4PHa9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Right of use liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">90,693</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--Liabilities_iI_zveO3qJbF5D4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total Liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">90,693</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 939327 85454 1024781 90693 90693 <p id="xdx_80B_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zzbB3x7stZJ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 6 – <span id="xdx_82D_z2sLeSJOrnnh">Equity</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Preferred shares</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are authorized to issue <span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_c20260630_z6mNTg0ajBJk" title="Preferred stock, shares authorized">5,000,000</span> shares of preferred stock. Shares of preferred stock may be issued from time to time in one or more series as may be determined by our Board. The voting powers and preferences, the relative rights of each such series and the qualifications, limitations and restrictions of each series will be established by the Board. Our directors may issue preferred stock with multiple votes per share and dividend rights which would have priority over any dividends paid with respect to the holders of our common stock. In connection with the Charter Amendment (as defined below), the only outstanding preferred stock was converted into common stock. As of the date of this report, there are <span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_c20260630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zLacwMWzHABh" title="Preferred stock, shares outstanding">2</span> outstanding shares of preferred stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Series D</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On </span>December 10, 2025, the Company filed with the Nevada Secretary of State a Certificate of Designation of Series D Preferred Stock. Pursuant to the Series D Preferred Stock Certificate of Designation, the Board designated a new series of the Company’s preferred stock, the Series D Preferred Stock, par value $<span id="xdx_90F_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20251210__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zGrHdGa295Zi" title="Preferred stock, par value">0.001</span> per share. The Series D Preferred Stock Certificate of Designation authorized the Company to issue <span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_dxL_c20251210__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_ziEcKBs7CcN2" title="Preferred stock, shares issued::XDX::2"><span style="-sec-ix-hidden: xdx2ixbrl0933">two</span></span> shares of Series D Preferred Stock. <span style="background-color: white">On </span>December 10, 2025, the Company issued to each of the officers <span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_dxL_c20251210__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember__srt--TitleOfIndividualAxis__srt--OfficerMember_zk0WgR3sCSQf" title="Preferred stock, shares issued::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl0935">one</span></span> share of Series D Preferred stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Series D Preferred Stock Certificate of Designation, holders of Series D Preferred Stock are entitled to vote together with the holders of common stock on all matters submitted to a vote of shareholders and each share of Series D Preferred Stock entitles the holder to voting power equal to 25.5% of the issued and outstanding shares of the Company’s common stock. The Series D Preferred Stock are not convertible, do not earn dividends, and are not redeemable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Common shares</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2026, the Company has authorized <span id="xdx_907_eus-gaap--CommonStockSharesAuthorized_iI_c20260630_zctBhqT6ci26" title="Common stock, shares authorized">7,000,000,000</span> shares of common stock, par value of $<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20260630_z0RkjHT5UIs9" title="Common stock, par value">0.001</span>, and, as of June 30, 2026, has issued <span id="xdx_90B_eus-gaap--CommonStockSharesIssued_iI_c20260630_z5rZStpuADW9" title="Common stock, shares issued">4,279,853,240</span> shares of common stock. All of the common shares have the same voting rights and liquidation preferences.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the six months ended June 30, 2026, the Company issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pp0p0_c20260101__20260630__srt--CounterpartyNameAxis__custom--PrivateInvestorMember_z2LuqB0um3zi" title="Stock issued new, shares">5,000,000</span> shares of common stock for cash proceeds of $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20260101__20260630__srt--CounterpartyNameAxis__custom--PrivateInvestorMember_zbohDQu6bYaf" title="Proceeds from issuance of common stock">150,010</span> with a private investor.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the six months ended June 30, 2026, the Company has issued an aggregate of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20260101__20260630_zaXD9ej2XcSg" title="Restricted stock issued, shares">16,500,000</span> shares of restricted common stock for services to outside consultants with an aggregate fair value of $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20260101__20260630_zDue5MdDkHr5" title="Restricted stock issued, value">269,500</span>. In addition, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20260101__20260630__srt--TitleOfIndividualAxis__srt--DirectorMember_zuNAdosnHWHe">10,000,000</span> shares of restricted common stock to a director of the Company, with a fair value of $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20260101__20260630__srt--TitleOfIndividualAxis__srt--DirectorMember_zDIdhUJyIIec">37,000</span>. On the date of issuance, the shares are fully earned and non-forfeitable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the six months ended June 30, 2026, the Company has issued an aggregate of <span id="xdx_90F_eus-gaap--ConversionOfStockSharesIssued1_pp0p0_c20260101__20260630__us-gaap--StatementClassOfStockAxis__custom--RestrictedCommonStockMember__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--CashlessExerciseOfWarrantsMember_ztWdP7F5ayA9" title="Conversion of stock, shares issued">63,912,296</span> shares of restricted common stock for the cashless exercise of an aggregate of <span id="xdx_909_eus-gaap--ConversionOfStockSharesConverted1_pp0p0_c20260101__20260630__us-gaap--StatementClassOfStockAxis__custom--WarrantsMember__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--CashlessExerciseOfWarrantsMember_zUbOwwJASTJ9" title="Conversion of stock, shares converted">84,000,000</span> common stock warrants held by 3 warrant holders.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the six months ended June 30, 2026, the Company has issued an aggregate of <span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20260101__20260630__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--ConvertibleNotesConversionMember_zfvahUJCysdg" title="Debt converted, shares issued">580,971,066</span> shares of common stock for the conversion of $<span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20260101__20260630__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--ConvertibleNotesConversionMember_z2ohBB3PTNBb" title="Debt converted, amount converted">624,075</span> in principal on outstanding convertible notes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Equity Line of Credit Agreement</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 4, 2025, the Company entered into a Securities Purchase Agreement (the “ELOC Agreement”) with an accredited investor purchaser. Pursuant to the ELOC Agreement, the Company agreed to sell, and the purchaser agreed to purchase up to $50,000,000 (the “Commitment Amount”) of the Company’s common stock, par value $0.001 per share (the “Purchase Shares”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The transactions contemplated by the ELOC Agreement are subject to the Company registering the Investor’s resale of the Purchase Shares on a registration statement to be filed with the Securities and Exchange Commission (“SEC”). Concurrent with the execution of the ELOC Agreement, the Company entered into a registration rights agreement with the Investor (the “Registration Rights Agreement”). Pursuant to the Registration Rights Agreement, the Company agreed to file a registration statement on Form S-1 (the “ELOC Registration Statement”) with the SEC covering the resale of the Purchase Shares sold under the ELOC, within 45 days of the date of execution of the ELOC Agreement and Registration Rights Agreement and to use its best efforts to have the Registration Statement and any amendment declared effective by the SEC at the earliest possible date. The registration rights granted under the Registration Rights Agreement are subject to certain conditions and limitations and are subject to customary indemnification and contribution provisions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with entering into the ELOC Agreement, the Company agreed to immediately issue to the purchaser, <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250903__20250904__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z4NFs0ed7jLk" title="Restricted stock issued, shares">25,000,000</span> restricted shares of common stock as commitment shares. The commitment shares were recorded at their fair value based on the closing price on date of issuance, or $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20250903__20250904__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zGeAGnQkFTlh">495,000</span> and are recorded as deferred offering cost and will reduce the net proceeds received once the ELOC shares are sold.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the six months ended June 30, 2026, the Company has issued <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--FinancialInstrumentAxis__custom--ELOCMember_z1LBRkWCRgZg" title="Stock issued new, shares">70,781,966</span> shares of common stock under the ELOC for cash proceeds of $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20260101__20260630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--FinancialInstrumentAxis__custom--ELOCMember_zUNNW9MbyxG7">702,125</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Stock Options</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 22, 2026, as discussed in Note 5, the Company granted to BAIF, or its assignee, the First Mora Option to purchase up to 250,000,000 shares of the Company’s common stock at an exercise price of $0.02 per share. The First Mora Option is fully vested and exercisable upon the grant date and terminates on the earlier of (i) five years following the date of the First Mora Option or (ii) the termination of the JVA. The options were valued using the Black-Scholes option pricing model and determined to have a fair value of $<span id="xdx_906_eus-gaap--AcquisitionCosts_c20260121__20260122__us-gaap--AwardTypeAxis__custom--FirstMoraOptionMember_zSU1cUKuYfp5" title="Acquisition costs">7,999,650</span> which were recorded as acquisition costs in the accompanying consolidated statement of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 22, 2026, as discussed in Note 5, the Company granted to BAIF, or its assignee, the Second Mora Option to acquire 150,000,000 shares of the Company’s common stock at an exercise price of $0.02 per share. The Second Mora Option is fully vested and exercisable as of the grant date and terminates on the earlier of (i) five years following the date of the Second Mora Option or (ii) the termination of the JVA. The options were valued using the Black-Scholes option pricing model and determined to have a fair value of $<span id="xdx_90C_eus-gaap--AcquisitionCosts_c20260121__20260122__us-gaap--AwardTypeAxis__custom--SecondMoraOptionMember_zlQSDSWLCfkf" title="Acquisition costs">4,949,786</span> which were recorded as acquisition costs in the accompanying consolidated statement of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On February 10, 2026, the board of directors of the Company (the “Board”) approved grants to each of Charles Faulkner and Simon Wajcenberg, the Chief Executive Officer and Chief Financial Officer of the Company, respectively, of options to purchase up to <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20260209__20260210__srt--CounterpartyNameAxis__custom--FaulknerAndWajcenbergMember_z07EebIPGbfg">350,000,000</span> shares of the Company’s common stock at an exercise price equal to the closing sale price of the Company’s common stock as reported by OTC Markets on the trading day immediately preceding the date of grant, exercisable for a term of five years in furtherance of their employment agreements with the Company. Each Stock Option shall be a non-qualified option. 50% of the shares underlying each Stock Option shall become vested and exercisable upon the closing of a purchase agreement between the Company, or the Company’s subsidiaries, and a solid oxide fuel cell supplier for a minimum power capacity of 100 MW, as determined by the Board, and the remaining 50% shall become vested and exercisable upon the closing of an AI data center site sale agreement between the Company, or the Company’s subsidiaries, and a buyer which is for a minimum capacity of 100 MW, as determined by the Board.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table summarizes the stock option activity for the six months ended June 30, 2026:</p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zbdiuYIwrWb8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Equity (Details - Stock option activity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B2_zQHNjlkUyGW8" style="display: none">Schedule of stock option activity</span></td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average Exercise Price Per Share</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%">Outstanding, December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zsDvZwGxBCm3" style="width: 13%; text-align: right" title="Options outstanding, beginning balance">598,475,414</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zQ6FohSTyH1a" style="width: 13%; text-align: right" title="Weighted-average exercise price per share, beginning balance">0.019</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zVK8oaekzZb" style="text-align: right" title="Options granted">1,100,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zunt5FhOB92d" style="text-align: right" title="Weighted-average exercise price per share, granted">0.005</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zuBOJIn1Oawc" style="text-align: right" title="Options exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zhNTk2Z3Gz8i" style="text-align: right" title="Weighted-average exercise price per share, exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_z6OLpL9QHT62" style="text-align: right" title="Options forfeited">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zpifuwmyXX1h" style="text-align: right" title="Weighted-average exercise price per share, forfeited">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Cancelled/Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zfre2CmU4cOi" style="border-bottom: Black 1pt solid; text-align: right" title="Options cancelled/expired">(400,000,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zyS4rdiYB3jf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted-average exercise price per share, cancelled/expired">0.002</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zdxmArfNAsug" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding, ending balance">1,298,475,414</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zD4NIIYqfqFc" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted-average exercise price per share, ending balance">0.012</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zKSXKYEzuk6a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2026, the Company had <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20260630_zZsIlsn8XmHh" title="Stock options exercisable">598,337,941</span> stock options that were exercisable, <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20260630_zDdQJth57G2k" title="Stock options exercisable">700,000,000</span> that are exercisable upon meeting certain performance vesting conditions and <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20260630__us-gaap--AwardTypeAxis__custom--OptionsInDisputeMember_zDG3bM84TWMk" title="Stock options, outstanding">137,473</span> that were in dispute. The weighted average remaining life of all outstanding stock options was <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260630_z48IjFjzvq9h" title="Weighted average remaining life">3.81</span> years as of June 30, 2026. The Company has $<span id="xdx_90A_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20260630__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--CryptoMiningMilestoneMember_zhZgg3Jsv1x7" title="Remaining share based compensation expense">10,497,922</span> of value remaining to be expensed based upon completions of milestones. Aggregate intrinsic value is calculated as the difference between the exercise price of the underlying stock option and the fair value of the Company’s common stock for stock options that were in-the-money at period end. As of June 30, 2026, the intrinsic value for the options vested and outstanding was $<span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20260630_zRmePWLq3cmg" title="Intrinsic value, options vested">0</span> and $<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20260630_zrALbbCCc1Mg" title="Intrinsic value, options outstanding">522</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -1.5pt"><i>Stock Warrants</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes the stock warrant activity for the six months ended June 30, 2026:</p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z21WMgL8a2v" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Equity (Details - Warrant activity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BB_zbRRPw5VduS7" style="display: none">Schedule of stock warrant activity</span></td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average Exercise Price Per Share</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Outstanding, December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zHaoS8hqVHih" style="width: 13%; text-align: right" title="Warrants outstanding, beginning balance">300,800,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zVkOiOxNrfSd" style="width: 13%; text-align: right" title="Weighted-average exercise price per share, beginning balance">0.01</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z4hsxwYJhDVg" style="text-align: right" title="Warrants granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z0hJQjKNmW87" style="text-align: right" title="Weighted-average exercise price per share, warrants granted">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zQQI5EHwNvFk" style="text-align: right" title="Warrants exercised">(84,000,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zfeGkdqjeiL9" style="text-align: right" title="Weighted-average exercise price per share, warrants exercised">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zhp5AODO7EW9" style="text-align: right" title="Warrants forfeited">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodWeightedAverageExercisePrice_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zlqy7Z9GBdef" style="text-align: right" title="Weighted-average exercise price per share, warrants forfeited">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zpMhAf8Vd592" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriodWeightedAverageExercisePrice_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zNXbFDZnM40j" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted-average exercise price per share, warrants expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Outstanding, June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zPSK4JKyfNpi" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, ending balance">216,800,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zW0O5ITesbe4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted-average exercise price per share, ending balance">0.011</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zNSvWI4GcNna" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The weighted average remaining life of all outstanding stock warrants was <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20260101__20260630_zKVttvEgFDbd" title="Warrants outstanding term">0.40</span> years as of June 30, 2026. Aggregate intrinsic value is calculated as the difference between the exercise price of the underlying stock option and the fair value of the Company’s common stock for stock options that were in-the-money at period end. As of June 30, 2026, the intrinsic value for the warrants vested and outstanding was $<span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_c20260630_zMZtfvumgQab" title="Intrinsic value of warrants outstanding"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_c20260101__20260630_z1c3fz4TGV3h" title="Intrinsic value of warrants vested">0</span></span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 5000000 2 0.001 7000000000 0.001 4279853240 5000000 150010 16500000 269500 10000000 37000 63912296 84000000 580971066 624075 25000000 495000 70781966 702125 7999650 4949786 350000000 <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zbdiuYIwrWb8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Equity (Details - Stock option activity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B2_zQHNjlkUyGW8" style="display: none">Schedule of stock option activity</span></td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average Exercise Price Per Share</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%">Outstanding, December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zsDvZwGxBCm3" style="width: 13%; text-align: right" title="Options outstanding, beginning balance">598,475,414</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zQ6FohSTyH1a" style="width: 13%; text-align: right" title="Weighted-average exercise price per share, beginning balance">0.019</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zVK8oaekzZb" style="text-align: right" title="Options granted">1,100,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zunt5FhOB92d" style="text-align: right" title="Weighted-average exercise price per share, granted">0.005</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zuBOJIn1Oawc" style="text-align: right" title="Options exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zhNTk2Z3Gz8i" style="text-align: right" title="Weighted-average exercise price per share, exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_z6OLpL9QHT62" style="text-align: right" title="Options forfeited">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zpifuwmyXX1h" style="text-align: right" title="Weighted-average exercise price per share, forfeited">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Cancelled/Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zfre2CmU4cOi" style="border-bottom: Black 1pt solid; text-align: right" title="Options cancelled/expired">(400,000,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zyS4rdiYB3jf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted-average exercise price per share, cancelled/expired">0.002</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zdxmArfNAsug" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding, ending balance">1,298,475,414</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--OptionMember_zD4NIIYqfqFc" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted-average exercise price per share, ending balance">0.012</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 598475414 0.019 1100000000 0.005 -0 0 -0 0 400000000 0.002 1298475414 0.012 598337941 700000000 137473 P3Y9M21D 10497922 0 522 <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z21WMgL8a2v" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Equity (Details - Warrant activity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BB_zbRRPw5VduS7" style="display: none">Schedule of stock warrant activity</span></td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average Exercise Price Per Share</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Outstanding, December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zHaoS8hqVHih" style="width: 13%; text-align: right" title="Warrants outstanding, beginning balance">300,800,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zVkOiOxNrfSd" style="width: 13%; text-align: right" title="Weighted-average exercise price per share, beginning balance">0.01</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z4hsxwYJhDVg" style="text-align: right" title="Warrants granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z0hJQjKNmW87" style="text-align: right" title="Weighted-average exercise price per share, warrants granted">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zQQI5EHwNvFk" style="text-align: right" title="Warrants exercised">(84,000,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zfeGkdqjeiL9" style="text-align: right" title="Weighted-average exercise price per share, warrants exercised">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zhp5AODO7EW9" style="text-align: right" title="Warrants forfeited">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodWeightedAverageExercisePrice_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zlqy7Z9GBdef" style="text-align: right" title="Weighted-average exercise price per share, warrants forfeited">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zpMhAf8Vd592" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriodWeightedAverageExercisePrice_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zNXbFDZnM40j" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted-average exercise price per share, warrants expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Outstanding, June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zPSK4JKyfNpi" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, ending balance">216,800,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zW0O5ITesbe4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted-average exercise price per share, ending balance">0.011</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 300800000 0.01 0 0 84000000 0.01 0 0 0 0 216800000 0.011 P0Y4M24D 0 0 <p id="xdx_808_eus-gaap--DebtDisclosureTextBlock_zh3ehda1K6Jb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 7 – <span id="xdx_828_zEHJDBgyTU26">Notes Payable and Convertible Notes Payable</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Notes Payable</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has outstanding notes payables in the amount of $<span id="xdx_906_eus-gaap--NotesPayable_iI_pp0p0_c20220131_z74MSKeQYU6l" title="Notes payable">35,000</span>. These loans were advanced as due on demand and no communication has been received from the original lenders.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Convertible notes payable</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On August 15, 2025, the Company entered into a securities purchase agreement with an accredited investor, pursuant to which the Company sold the <span style="background-color: white">accredited investor</span> an unsecured original issue discount promissory note in the principal amount of $<span id="xdx_90F_eus-gaap--ConvertibleNotesPayable_iI_c20250815__us-gaap--LongtermDebtTypeAxis__custom--August2025SPAMember_zitQW4Sfxud8" title="Convertible notes payable">81,600</span>. The Company received net proceeds of $<span id="xdx_901_eus-gaap--ProceedsFromConvertibleDebt_c20250814__20250815__us-gaap--LongtermDebtTypeAxis__custom--August2025SPAMember_zpRXii58JVT" title="Proceeds from convertible debt">60,000</span> after original issue discount of $<span id="xdx_90F_eus-gaap--PaymentsOfDebtIssuanceCosts_c20250814__20250815__us-gaap--LongtermDebtTypeAxis__custom--August2025SPAMember__us-gaap--TransactionTypeAxis__custom--OriginalIssueDiscountMember_zllaOFp4ablj" title="Payment of debt issuance costs">13,600</span> and legal fees of $<span id="xdx_905_eus-gaap--PaymentsOfDebtIssuanceCosts_c20250814__20250815__us-gaap--LongtermDebtTypeAxis__custom--August2025SPAMember__us-gaap--TransactionTypeAxis__custom--LegalFeesMember_zyY8KS7Inw05" title="Payment of debt issuance costs">8,000</span>. The Promissory Note shall incur a one-time interest charge of 15% equal to $<span id="xdx_90C_eus-gaap--InterestExpenseDebt_c20250814__20250815__us-gaap--LongtermDebtTypeAxis__custom--August2025SPAMember_z2L5lBfHEGC7" title="Interest expense">12,240</span>, which is added to the principal balance, has a maturity date of <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20250814__20250815__us-gaap--LongtermDebtTypeAxis__custom--August2025SPAMember_zY3frMNsUIbj" title="Maturity date">May 16, 2026</span>. The note is convertible into common shares of the Company upon an event of default, at a rate of 71% of the lowest price for the preceding 20 trading days. The aggregate debt discount of $<span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250815__us-gaap--LongtermDebtTypeAxis__custom--August2025SPAMember_zChnqdRTzIDh" title="Unamortized debt discount">33,840</span> is being amortized to interest expense over the respective term of the note. During the six months ended June 30, 2026, the Company repaid $<span id="xdx_903_eus-gaap--RepaymentsOfConvertibleDebt_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--August2025SPAMember_zEbnxvpiwR55" title="Repayments of convertible debt">53,840</span> of the note balance and the lender converted $<span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--August2025SPAMember_zit3MD3R5ny" title="Debt converted, amount converted">40,000</span> into common shares. See Note 6 “<span style="text-decoration: underline">Equity</span>.” As of June 30, 2026, the note has been settled in full.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">On September 2, 2025, the Company entered into a securities purchase agreement with ClearThink Capital Partners, LLC (“ClearThink”), pursuant to which the Company sold ClearThink the “First Promissory Note” in the principal amount of $<span id="xdx_90B_eus-gaap--ConvertibleNotesPayable_iI_c20250902__us-gaap--LongtermDebtTypeAxis__custom--Sept2025ClearThinkNoteMember_zsG9hjiySEs6">172,500</span> for which the Company received net proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_c20250901__20250902__us-gaap--LongtermDebtTypeAxis__custom--Sept2025ClearThinkNoteMember_zvzznF80vnXc">150,000</span> </span>after original issue discount of $<span id="xdx_901_eus-gaap--PaymentsOfDebtIssuanceCosts_c20250901__20250902__us-gaap--LongtermDebtTypeAxis__custom--Sept2025ClearThinkNoteMember_zZr1rq3ddoLi">22,500</span><span style="background-color: white">. </span>The First Promissory Note shall incur a one-time interest charge of 12% equal to $<span id="xdx_90D_eus-gaap--InterestExpenseDebt_c20250901__20250902__us-gaap--LongtermDebtTypeAxis__custom--Sept2025ClearThinkNoteMember_zEJnbKBo6Dkf">20,700</span>, which is added to the principal balance, has a maturity date of <span id="xdx_900_eus-gaap--DebtInstrumentMaturityDate_dd_c20250901__20250902__us-gaap--LongtermDebtTypeAxis__custom--Sept2025ClearThinkNoteMember_zQKsL4cBWapj" title="Maturity date">August 31, 2026</span>. The note is convertible into common shares of the Company after 180 days, at a rate of $0.01, but in the event the trading price is below $0.01 for 5 consecutive trading days the conversion price resets to $0.0075; if the trading price falls below $0.0075 for 5 consecutive days, the fixed price is eliminated and re-adjusted every 21 days. The aggregate debt discount of $<span id="xdx_90C_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250902__us-gaap--LongtermDebtTypeAxis__custom--Sept2025ClearThinkNoteMember_zUzM66urQbP9" title="Aggregate debt discount">43,200</span> is being amortized to interest expense over the respective term of the note. During the six months ended June 30, 2026, the Company incurred a default penalty of $<span id="xdx_90B_eus-gaap--InterestExpenseDebt_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--Sept2025ClearThinkNoteMember__us-gaap--TransactionTypeAxis__custom--DefaultPenaltyMember_z8CWNYi5OfPh" title="Interest expense">96,600</span> which was charged to interest expense and the lender converted $<span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--Sept2025ClearThinkNoteMember_zUeWbR45fza7">99,000</span> into common shares. See Note 6 “<span style="text-decoration: underline">Equity</span>.” As of June 30, 2026, the balance on the note is $<span id="xdx_902_eus-gaap--ConvertibleNotesPayable_iI_c20260630__us-gaap--LongtermDebtTypeAxis__custom--Sept2025ClearThinkNoteMember_zHYAEtc6cIOl" title="Convertible notes payable">190,800</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">On September 9, 2025, the Company entered into a securities purchase agreement with an accredited investor, pursuant to which the Company sold the accredited investor an unsecured original issue discount promissory note in the principal amount of $<span id="xdx_90B_eus-gaap--ConvertibleNotesPayable_iI_c20250909__us-gaap--LongtermDebtTypeAxis__custom--Sept92025SPAMember_zmCkffgvUtCa">81,600</span> for which </span>the Company received net proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromConvertibleDebt_c20250908__20250909__us-gaap--LongtermDebtTypeAxis__custom--Sept92025SPAMember_zsmxN5akeEHj">60,000</span> after original issue discount of $<span id="xdx_906_eus-gaap--PaymentsOfDebtIssuanceCosts_c20250908__20250909__us-gaap--LongtermDebtTypeAxis__custom--Sept92025SPAMember__us-gaap--TransactionTypeAxis__custom--OriginalIssueDiscountMember_zZe02AJaLs48" title="Payment of debt issuance costs">13,600</span> and legal fees of $<span id="xdx_903_eus-gaap--PaymentsOfDebtIssuanceCosts_c20250908__20250909__us-gaap--LongtermDebtTypeAxis__custom--Sept92025SPAMember__us-gaap--TransactionTypeAxis__custom--LegalFeesMember_zF6miAOJhzSg" title="Payment of debt issuance costs">8,000</span><span style="background-color: white">. </span>The note is convertible into common shares of the Company upon an event of default, at a rate of 71% of the lowest price for the preceding 20 trading days. The aggregate debt discount of $<span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250909__us-gaap--LongtermDebtTypeAxis__custom--Sept92025SPAMember_z9TKiwgWOU2k">21,600</span> is being amortized to interest expense over the respective term of the note. During the six months ended June 30, 2026, the Company repaid $<span id="xdx_90A_eus-gaap--RepaymentsOfConvertibleDebt_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--Sept92025SPAMember_zjABbCuoIVic">123,580</span> to settle the balance of the note in full which included an interest charge of $<span id="xdx_90B_eus-gaap--RepaymentsOfConvertibleDebt_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--Sept92025SPAMember__us-gaap--TransactionTypeAxis__us-gaap--InterestChargeMember_zi9AOMbiEmcc">29,740</span>. As of June 30, 2026, the balance of the note has been settled in full.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">On September 15, 2025, the Company entered into a securities purchase agreement with an accredited investor, pursuant to which the Company sold an accredited investor an unsecured original issue discount promissory note in the principal amount of $<span id="xdx_903_eus-gaap--ConvertibleNotesPayable_iI_c20250915__us-gaap--LongtermDebtTypeAxis__custom--Sept152025SPAMember_z1MM0zfRJgN8">287,500</span> for which the Company received net proceeds of $<span id="xdx_903_eus-gaap--ProceedsFromConvertibleDebt_c20250914__20250915__us-gaap--LongtermDebtTypeAxis__custom--Sept152025SPAMember_z2TvU95OElda">244,000</span> </span>after original issue discount of $<span id="xdx_90E_eus-gaap--PaymentsOfDebtIssuanceCosts_c20250914__20250915__us-gaap--LongtermDebtTypeAxis__custom--Sept152025SPAMember__us-gaap--TransactionTypeAxis__custom--OriginalIssueDiscountMember_zQS3WeIAQsZe" title="Payment of debt issuance costs">37,500</span> and legal fees of $<span id="xdx_907_eus-gaap--PaymentsOfDebtIssuanceCosts_c20250914__20250915__us-gaap--LongtermDebtTypeAxis__custom--Sept152025SPAMember__us-gaap--TransactionTypeAxis__custom--LegalFeesMember_z058RDpaQ003" title="Payment of debt issuance costs">6,000</span><span style="background-color: white">. </span>The promissory note shall incur a one-time interest charge of 10% equal to $<span id="xdx_90F_eus-gaap--InterestExpenseDebt_c20250914__20250915__us-gaap--LongtermDebtTypeAxis__custom--Sept152025SPAMember_znjOxWe6qkq3">28,750</span>, which is added to the principal balance, and has a maturity date of <span id="xdx_905_eus-gaap--DebtInstrumentMaturityDate_dd_c20250914__20250915__us-gaap--LongtermDebtTypeAxis__custom--Sept152025SPAMember_zP7zhmy06Fzj">September 15, 2026</span>. <span style="background-color: white">In connection with the agreement, the Company issued to the accredited investor <span id="xdx_90F_ecustom--SharesIssuedForNoteInducementShares_c20250914__20250915__us-gaap--LongtermDebtTypeAxis__custom--Sept152025SPAMember_zylB6L0A7Rqd" title="Stock issued for note inducement, shares">8,500,000</span> shares of common stock as inducement shares with relative fair value of $<span id="xdx_90A_ecustom--SharesIssuedForNoteInducement_c20250914__20250915__us-gaap--LongtermDebtTypeAxis__custom--Sept152025SPAMember_zjZRbPbTMNml" title="Stock issued for note inducement, value">174,517</span> which was recorded as a discount on the note. </span>The note is convertible into common shares of the Company, at the lower of $0.01 or 65% of the lowest price for the preceding 10 trading days. As a result of the variable conversion rate, the conversion feature must be separated from the note resulting in derivative liability accounting under ASC 815. The fair value of the derivative on the date of issuance was recorded as a debt discount up to the face value of the note with the excess being charged directly to interest expense. See further discussion under “Note 8. <span style="text-decoration: underline">Derivative Liabilities</span>.” The aggregate debt discount of $<span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250915__us-gaap--LongtermDebtTypeAxis__custom--Sept152025SPAMember_z6Im8zx808Xe">316,250</span> is being amortized to interest expense over the respective term of the note. During the six months ended June 30, 2026, the lender converted $<span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--Sept152025SPAMember_zck2suOYcfTl">178,125</span> into common shares. See Note 6 “<span style="text-decoration: underline">Equity</span>.” As of June 30, 2026, the balance on the note is $<span id="xdx_905_eus-gaap--ConvertibleNotesPayable_iI_c20260630__us-gaap--LongtermDebtTypeAxis__custom--Sept152025SPAMember_zNByhS5z0BR8">138,125</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On September 18, 2025, the Company entered into a securities purchase agreement with an accredited investor, pursuant to which the Company sold an unsecured original issue discount promissory note in the principal amount of $<span id="xdx_901_eus-gaap--ConvertibleNotesPayable_iI_c20250918__us-gaap--LongtermDebtTypeAxis__custom--Sept182025SPAMember_z3HqOXqq0Roe">115,000</span> for which the Company received net proceeds of $<span id="xdx_901_eus-gaap--ProceedsFromConvertibleDebt_c20250917__20250918__us-gaap--LongtermDebtTypeAxis__custom--Sept182025SPAMember_zoehlVSsY8ng">94,000</span> </span>after original issue discount of $<span id="xdx_90E_eus-gaap--PaymentsOfDebtIssuanceCosts_c20250917__20250918__us-gaap--LongtermDebtTypeAxis__custom--Sept182025SPAMember__us-gaap--TransactionTypeAxis__custom--OriginalIssueDiscountMember_zn1UehIjAtkk" title="Payment of debt issuance costs">15,000</span> and legal fees of $<span id="xdx_90A_eus-gaap--PaymentsOfDebtIssuanceCosts_c20250917__20250918__us-gaap--LongtermDebtTypeAxis__custom--Sept182025SPAMember__us-gaap--TransactionTypeAxis__custom--LegalFeesMember_zzGQXGYVC0Yc" title="Payment of debt issuance costs">6,000</span><span style="background-color: white">. </span>The promissory note shall incur a one-time interest charge of 10% equal to $<span id="xdx_90B_eus-gaap--InterestExpenseDebt_c20250917__20250918__us-gaap--LongtermDebtTypeAxis__custom--Sept182025SPAMember_zsNLQU8Vgxb">9,200</span>, which is added to the principal balance, and has a maturity date of <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20250917__20250918__us-gaap--LongtermDebtTypeAxis__custom--Sept182025SPAMember_zxynrMAk5s8c">September 18, 2026</span>. <span style="background-color: white">In connection with the agreement, the Company issued to the accredited investor <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250917__20250918__us-gaap--LongtermDebtTypeAxis__custom--Sept182025SPAMember__us-gaap--TransactionTypeAxis__custom--CommitmentSharesMember_zDzgNxW2SrNb">3,400,000</span> shares of common stock as commitment shares. The proceeds from the sale of the unsecured original issue discount promissory note shall be used for working capital. </span>The Company paid $6,000 to the accredited investor and its counsel for legal fees. The note is convertible into common shares of the Company, at a rate of $0.01 and if after 180 days, the trading price is below $0.01 for 5 consecutive trading days the conversion price resets to $0.0075; if the trading price falls below $0.0075 for 5 consecutive days, the fixed price is eliminated and re-adjusted every 21 days. As a result of the variable conversion rate on the other outstanding notes, the conversion feature must be separated from the note resulting in derivative liability accounting under ASC 815. The fair value of the derivative on the date of issuance was recorded as a debt discount up to the face value of the note with the excess being charged directly to interest expense. See further discussion under “Note 8. <span style="text-decoration: underline">Derivative Liabilities</span>.” The aggregate debt discount of $<span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250918__us-gaap--LongtermDebtTypeAxis__custom--Sept182025SPAMember_zp1ukW7F4p71">121,000</span> is being amortized to interest expense over the respective term of the note. During the six months ended June 30, 2026, the lender converted $<span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--Sept182025SPAMember_zMDHvZkFtYi3">93,950</span> into common shares. See Note 6 “<span style="text-decoration: underline">Equity</span>.” As of June 30, 2026, the balance on the note is $<span id="xdx_90D_eus-gaap--ConvertibleNotesPayable_iI_c20260630__us-gaap--LongtermDebtTypeAxis__custom--Sept182025SPAMember_zLUlykp7u75c">30,250</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On September 23, 2025, the Company entered into a security purchase agreement with an accredited investor, pursuant to which the Company sold an unsecured original issue discount promissory note in the principal amount of $<span id="xdx_909_eus-gaap--ConvertibleNotesPayable_iI_c20250923__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SPAMember_zqdBU5nnuUTl">143,750</span> for which the Company received net proceeds of $<span id="xdx_909_eus-gaap--ProceedsFromConvertibleDebt_c20250922__20250923__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SPAMember_zDtRbQ61wh2e">119,000</span> </span>after original issue discount of $<span id="xdx_90E_eus-gaap--PaymentsOfDebtIssuanceCosts_c20250922__20250923__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SPAMember__us-gaap--TransactionTypeAxis__custom--OriginalIssueDiscountMember_zjO60VCpdulk" title="Payment of debt issuance costs">18,750</span> and legal fees of $<span id="xdx_905_eus-gaap--PaymentsOfDebtIssuanceCosts_c20250922__20250923__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SPAMember__us-gaap--TransactionTypeAxis__custom--LegalFeesMember_zvWwEXMdPPs4" title="Payment of debt issuance costs">6,000</span><span style="background-color: white">. </span>The promissory note shall incur a one-time interest charge of 10% equal to $<span id="xdx_90E_eus-gaap--InterestExpenseDebt_c20250922__20250923__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SPAMember_zHHPTOMgF6Kk">14,375</span>, which is added to the principal balance, and has a maturity date of <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20250922__20250923__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SPAMember_zDj9gCBXWB11">September 23, 2026</span>. <span style="background-color: white">In connection with the agreement, the Company issued to the accredited investor <span id="xdx_907_ecustom--SharesIssuedForNoteInducementShares_c20250922__20250923__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SPAMember_zGxdI8vn1ZBi" title="Stock issued for note inducement, shares">4,250,000</span> shares of common stock as inducement shares with a relative fair value of $<span id="xdx_90F_ecustom--SharesIssuedForNoteInducement_c20250922__20250923__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SPAMember_zrGvZi5KC6Af" title="Stock issued for note inducement, value">71,400</span> which was recorded as a discount on the note.</span> The note is convertible into common shares of the Company, at the lower of $0.01 or 65% of the lowest price for the preceding 10 trading days. As a result of the variable conversion rate, the conversion feature must be separated from the note resulting in derivative liability accounting under ASC 815. The fair value of the derivative on the date of issuance was recorded as a debt discount up to the face value of the note with the excess being charged directly to interest expense. See further discussion under “Note 8. <span style="text-decoration: underline">Derivative Liabilities</span>.” The aggregate debt discount of $<span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250923__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SPAMember_z1BiuJ8eIqAi">158,125</span> is being amortized to interest expense over the respective term of the note. During the six months ended June 30, 2026, the Company incurred a default penalty of $<span id="xdx_901_eus-gaap--InterestExpenseDebt_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SPAMember__us-gaap--TransactionTypeAxis__custom--DefaultPenaltyMember_zC5HoZWbLI82" title="Interest expense">79,063</span> which was charged to interest expense and the lender converted $<span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SPAMember_zWhkbW4wcjnd">127,500</span> into common shares. See Note 6 “<span style="text-decoration: underline">Equity</span>.” As of June 30, 2026, the balance on the note is $<span id="xdx_90E_eus-gaap--ConvertibleNotesPayable_iI_c20260630__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SPAMember_zde6iwZzNkO3">109,688</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On September 23, 2025, the Company entered into a second security purchase agreement with an accredited investor, pursuant to which the Company sold an unsecured original issue discount promissory note in the principal amount of $<span id="xdx_90E_eus-gaap--ConvertibleNotesPayable_iI_c20250923__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SecondSPAMember_zFqJJ3wZ4m56">143,750</span> for which the Company received net proceeds of $<span id="xdx_90D_eus-gaap--ProceedsFromConvertibleDebt_c20250922__20250923__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SecondSPAMember_zySENGfTTEW2">119,000</span> </span>after original issue discount of $<span id="xdx_908_eus-gaap--PaymentsOfDebtIssuanceCosts_c20250922__20250923__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SecondSPAMember__us-gaap--TransactionTypeAxis__custom--OriginalIssueDiscountMember_zgWG0u8LxkG5" title="Payment of debt issuance costs">18,750</span> and legal fees of $<span id="xdx_903_eus-gaap--PaymentsOfDebtIssuanceCosts_c20250922__20250923__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SecondSPAMember__us-gaap--TransactionTypeAxis__custom--LegalFeesMember_z3SIINgweTk3" title="Payment of debt issuance costs">6,000</span><span style="background-color: white">. </span>The promissory note shall incur a one-time interest charge of 10% equal to $<span id="xdx_901_eus-gaap--InterestExpenseDebt_c20250922__20250923__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SecondSPAMember_znFtm9yaAlda">14,375</span>, which is added to the principal balance, and has a maturity date of <span id="xdx_900_eus-gaap--DebtInstrumentMaturityDate_dd_c20250922__20250923__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SecondSPAMember_zRIczkU2UaPd">September 23, 2026</span>. <span style="background-color: white">In connection with the agreement, the Company issued to the accredited investor <span id="xdx_905_ecustom--SharesIssuedForNoteInducementShares_c20250922__20250923__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SecondSPAMember_zHWtpzXj5fze" title="Stock issued for note inducement, shares">4,250,000</span> shares of common stock as inducement shares with a relative fair value of $<span id="xdx_900_ecustom--SharesIssuedForNoteInducement_c20250922__20250923__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SecondSPAMember_zL4U5YPODzXg" title="Stock issued for note inducement, value">71,400</span> which was recorded as a discount on the note. </span>The note is convertible into common shares of the Company, at the lower of $0.01 or 65% of the lowest price for the preceding 10 trading days. As a result of the variable conversion rate, the conversion feature must be separated from the note resulting in derivative liability accounting under ASC 815. The fair value of the derivative on the date of issuance was recorded as a debt discount up to the face value of the note with the excess being charged directly to interest expense. See further discussion under “Note 8. <span style="text-decoration: underline">Derivative Liabilities</span>.” The aggregate debt discount of $<span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250923__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SecondSPAMember_zqlssAbOi1g2">158,125</span> is being amortized to interest expense over the respective term of the note. During the six months ended June 30, 2026, the Company incurred a default penalty of $<span id="xdx_905_eus-gaap--InterestExpenseDebt_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SecondSPAMember__us-gaap--TransactionTypeAxis__custom--DefaultPenaltyMember_z3Z2Sc1MO3S8" title="Interest expense">79,063</span> which was charged to interest expense and the lender converted $<span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20260101__20260630__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SecondSPAMember_zUI0GqMlsYL7">71,500</span> into common shares. See Note 6 “<span style="text-decoration: underline">Equity</span>.” As of June 30, 2026, the balance on the note is $<span id="xdx_909_eus-gaap--ConvertibleNotesPayable_iI_c20260630__us-gaap--LongtermDebtTypeAxis__custom--Sept232025SecondSPAMember_z15zH5FWO2Z2">165,688</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 3, 2025, the Company entered into a securities purchase agreement dated September 30, 2025 with an accredited investor, pursuant to which the Company sold an unsecured original issue discount promissory note in the principal amount of $<span id="xdx_903_eus-gaap--ConvertibleNotesPayable_iI_c20251003__us-gaap--LongtermDebtTypeAxis__custom--Oct32025SPAMember_zF8ffJs1MYmh">287,500</span>. The Company received net proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20251002__20251003__us-gaap--LongtermDebtTypeAxis__custom--Oct32025SPAMember_z1JhnGIu05E2">250,000</span> after original discount of $<span id="xdx_900_eus-gaap--PaymentsOfDebtIssuanceCosts_c20251002__20251003__us-gaap--LongtermDebtTypeAxis__custom--Oct32025SPAMember__us-gaap--TransactionTypeAxis__custom--OriginalIssueDiscountMember_zJrAHe4eL5hb" title="Payment of debt issuance costs">37,500</span>. The promissory note shall incur a one-time interest charge of 12% equal to $<span id="xdx_90E_eus-gaap--InterestExpenseDebt_c20251002__20251003__us-gaap--LongtermDebtTypeAxis__custom--Oct32025SPAMember_z1Rdkuf6TGyj">34,500</span>, which is added to the principal balance and matures on <span id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_dd_c20251002__20251003__us-gaap--LongtermDebtTypeAxis__custom--Oct32025SPAMember_zZRsQNYIvCO3">August 31, 2026</span>. Pursuant to the securities purchase agreement, as consideration for the purchase of the unsecured original issue discount promissory note, the Company issued <span id="xdx_906_ecustom--SharesIssuedForNoteInducementShares_c20251002__20251003__us-gaap--LongtermDebtTypeAxis__custom--Oct32025SPAMember_zq7shut4vjg9">17,000,000</span> shares of the Company’s common stock to the accredited investor <span style="background-color: white">with a relative fair value of $<span id="xdx_905_ecustom--SharesIssuedForNoteInducement_c20251002__20251003__us-gaap--LongtermDebtTypeAxis__custom--Oct32025SPAMember_zFap210wvrRf">178,620</span> which was recorded as a discount on the note</span>. The note is convertible into common shares of the Company after 180 days, at a rate of $0.01, but in the event the trading price is below $0.01 for 5 consecutive trading days the conversion price resets to $0.0075; if the trading price falls below $0.0075 for 5 consecutive days, the fixed price is eliminated and re-adjusted every 21 days. The aggregate debt discount of $<span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20251003__us-gaap--LongtermDebtTypeAxis__custom--Oct32025SPAMember_zbIU8ZlzXfW8">16,120</span> is being amortized to interest expense over the respective term of the note. On March 30, 2026, after 180 days, the note became convertible into shares of common stock. As a result, the company recorded the fair value of the derivative liability which was charged directly to interest expense. As of June 30, 2026, the balance on the note is $<span id="xdx_90F_eus-gaap--ConvertibleNotesPayable_iI_c20260630__us-gaap--LongtermDebtTypeAxis__custom--Oct32025SPAMember_z5buK3pG34M5">322,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 8, 2025, the Company issued a convertible promissory note to an accredited investor for $<span id="xdx_90F_eus-gaap--ConvertibleNotesPayable_iI_c20251008__us-gaap--LongtermDebtTypeAxis__custom--Oct82025ConvNoteMember_zUILyaWqAsnh">20,000</span> to settle outstanding amounts owed to the investor. The note has a maturity date of <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20251007__20251008__us-gaap--LongtermDebtTypeAxis__custom--Oct82025ConvNoteMember_zX3c0sxxqVl4">October 8, 2026</span> and bears interest at a rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20251008__us-gaap--LongtermDebtTypeAxis__custom--Oct82025ConvNoteMember_zE4xhHm4HaSe">10</span>%. The note is convertible into common shares of the Company after 180 days, at a rate of 85% of the lowest closing bid price for the five trading days preceding the conversion date. On April 6, 2026, after 180 days, the note became convertible into shares of common stock. As a result, the company recorded the fair value of the derivative liability which was charged directly to interest expense. As of June 30, 2026, the balance on the note is $<span id="xdx_909_eus-gaap--ConvertibleNotesPayable_iI_c20260630__us-gaap--LongtermDebtTypeAxis__custom--Oct82025ConvNoteMember_z35wTERtKAbe">20,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 9, 2025, the Company entered into the “Second Promissory Note” with ClearThink in the principal amount of $<span id="xdx_908_eus-gaap--ConvertibleNotesPayable_iI_c20251009__us-gaap--LongtermDebtTypeAxis__custom--Oct92025ClearThinkNoteMember_z5k7HOI2wohb">115,000</span>. The Company received net proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromConvertibleDebt_c20251007__20251009__us-gaap--LongtermDebtTypeAxis__custom--Oct92025ClearThinkNoteMember_zamF5xnNec6e">100,000</span> after original discount of $<span id="xdx_90C_eus-gaap--PaymentsOfDebtIssuanceCosts_c20251007__20251009__us-gaap--LongtermDebtTypeAxis__custom--Oct92025ClearThinkNoteMember__us-gaap--TransactionTypeAxis__custom--OriginalIssueDiscountMember_zTmbLLAMupQ6" title="Payment of debt issuance costs">15,000</span>. The Second Promissory Note shall incur a one-time interest charge of 12% equal to $<span id="xdx_902_eus-gaap--InterestExpenseDebt_c20251007__20251009__us-gaap--LongtermDebtTypeAxis__custom--Oct92025ClearThinkNoteMember_z3qonow44xJd">13,800</span>, which is added to the principal balance and matures on <span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_dd_c20251007__20251009__us-gaap--LongtermDebtTypeAxis__custom--Oct92025ClearThinkNoteMember_zjyHQya9CEEj">August 31, 2026</span>. The note is convertible into common shares of the Company after 180 days, at a rate of $0.01, but in the event the trading price is below $0.01 for 5 consecutive trading days the conversion price resets to $0.0075; if the trading price falls below $0.0075 for 5 consecutive days, the fixed price is eliminated and re-adjusted every 21 days. The aggregate debt discount of $<span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20251009__us-gaap--LongtermDebtTypeAxis__custom--Oct92025ClearThinkNoteMember_zV7jH0uLCDU9">28,800</span> is being amortized to interest expense over the respective term of the note. On April 9, 2026, after 180 days, the note became convertible into shares of common stock. As a result, the company recorded the fair value of the derivative liability which was charged directly to interest expense. As of June 30, 2026, the balance on the note is $<span id="xdx_901_eus-gaap--ConvertibleNotesPayable_iI_c20260630__us-gaap--LongtermDebtTypeAxis__custom--Oct92025ClearThinkNoteMember_zBklUmfnn1T3">128,800</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 26, 2025, we issued a convertible promissory note dated November 20, 2025 to an accredited investor in the aggregate principal amount of $<span id="xdx_908_eus-gaap--ConvertibleNotesPayable_iI_c20251126__us-gaap--LongtermDebtTypeAxis__custom--Nov2025ConvNotePayableMember_zU2hvQKQ2K7f">143,750</span>. The Company received net proceeds of $<span id="xdx_909_eus-gaap--ProceedsFromConvertibleDebt_c20251125__20251126__us-gaap--LongtermDebtTypeAxis__custom--Nov2025ConvNotePayableMember_zTSpMRb13qul">125,000</span> after original discount of $<span id="xdx_900_eus-gaap--PaymentsOfDebtIssuanceCosts_c20251125__20251126__us-gaap--LongtermDebtTypeAxis__custom--Nov2025ConvNotePayableMember__us-gaap--TransactionTypeAxis__custom--OriginalIssueDiscountMember_ziRhFd4W8vuj" title="Payment of debt issuance costs">18,750</span>. The promissory note shall incur a one-time interest charge of 12% equal to $<span id="xdx_902_eus-gaap--InterestExpenseDebt_c20251125__20251126__us-gaap--LongtermDebtTypeAxis__custom--Nov2025ConvNotePayableMember_z3E8eXocBLLc">18,750</span>, which is added to the principal balance and matures on <span id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_dd_c20251125__20251126__us-gaap--LongtermDebtTypeAxis__custom--Nov2025ConvNotePayableMember_zXIWqbxygoV9">November 20, 2026</span>. Pursuant to the securities purchase agreement, as consideration for the purchase of the unsecured original issue discount promissory note, the Company issued <span id="xdx_902_ecustom--SharesIssuedForNoteInducementShares_c20251125__20251126__us-gaap--LongtermDebtTypeAxis__custom--Nov2025ConvNotePayableMember_zlATNgOX3tBg" title="Stock issued for note inducement, shares">1,250,000</span> shares of the Company’s common stock to the accredited investor <span style="background-color: white">with a relative fair value of $<span id="xdx_90B_ecustom--SharesIssuedForNoteInducement_c20251125__20251126__us-gaap--LongtermDebtTypeAxis__custom--Nov2025ConvNotePayableMember_zONZHzqtWMwc">25,794</span> which was recorded as a discount on the note</span>. The note is convertible at a price of $0.01 per share and, in the event that, 180 days after the date of issuance, the closing price of our common stock is less than $0.01 per share for more than five consecutive trading days, the conversion price shall reset to $0.0075. The aggregate debt discount of $<span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20251126__us-gaap--LongtermDebtTypeAxis__custom--Nov2025ConvNotePayableMember_z9xBTe5Cbx4e">63,294</span> is being amortized to interest expense over the respective term of the note. On May 19, 2026, after 180 days, the note became convertible into shares of common stock. As a result, the company recorded the fair value of the derivative liability which was charged directly to interest expense. As of June 30, 2026, the balance on the note is $<span id="xdx_902_eus-gaap--ConvertibleNotesPayable_iI_c20260630__us-gaap--LongtermDebtTypeAxis__custom--Nov2025ConvNotePayableMember_zfKWPXRRkmI1">162,500</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 12, 2026, the Company entered into a securities purchase agreement with an accredited investor. Pursuant to the securities purchase agreement, the Company sold the investor an original issue discount promissory note in the principal amount of $<span id="xdx_90D_eus-gaap--ConvertibleNotesPayable_iI_c20260112__us-gaap--LongtermDebtTypeAxis__custom--Jan122026SPAMember_zocNMSYqXCEb">81,250</span> for which the Company received net proceeds of $<span id="xdx_900_eus-gaap--ProceedsFromConvertibleDebt_c20260111__20260112__us-gaap--LongtermDebtTypeAxis__custom--Jan122026SPAMember_zxCE36CV5yi1">71,000</span>. The promissory note carries an interest rate of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20260112__us-gaap--LongtermDebtTypeAxis__custom--Jan122026SPAMember_znXRqZJOYqGi">12</span>% per annum and has maturity date of <span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_dd_c20260111__20260112__us-gaap--LongtermDebtTypeAxis__custom--Jan122026SPAMember_z803l6qCZJig">January 12, 2027</span>. The promissory note is convertible into shares of the Company’s common stock 180 days after issuance at a price equal to 70% of the lowest traded price of the Company’s common stock on its principal trading market during the 20 trading days preceding the date of conversion. The aggregate debt discount of $<span id="xdx_90B_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20260112__us-gaap--LongtermDebtTypeAxis__custom--Jan122026SPAMember_zbzXrx1LZeIk">10,250</span> is being amortized to interest expense over the respective term of the note. As of June 30, 2026, the balance on the note is $<span id="xdx_907_eus-gaap--ConvertibleNotesPayable_iI_c20260630__us-gaap--LongtermDebtTypeAxis__custom--Jan122026SPAMember_zn7TIDbUxPU3">81,250</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 27, 2026, the Company entered into a securities purchase agreement with an accredited investor. Pursuant to the securities purchase agreement, the Company sold the Investor an unsecured original issue discount promissory note in the principal amount of $<span id="xdx_908_eus-gaap--ConvertibleNotesPayable_iI_c20260127__us-gaap--LongtermDebtTypeAxis__custom--Jan272026SPAMember_z4u6n9M5Mo0e">86,250</span> for which the Company received net proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromConvertibleDebt_c20260126__20260127__us-gaap--LongtermDebtTypeAxis__custom--Jan272026SPAMember_zT4DhFK3pHu4">72,500</span>. The promissory note carries a one-time interest charge of 10% of $<span id="xdx_90C_eus-gaap--InterestExpenseDebt_c20260126__20260127__us-gaap--LongtermDebtTypeAxis__custom--Jan272026SPAMember_zAngPO28yKJi">8,625</span> which is added to the principal balance, payable on the maturity date of <span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_dd_c20260126__20260127__us-gaap--LongtermDebtTypeAxis__custom--Jan272026SPAMember_zbCTvUiqawZ3">January 27, 2027</span> or upon acceleration or prepayment of the promissory note. Further, as consideration for the purchase of the promissory note, the Company also issued <span id="xdx_903_ecustom--SharesIssuedForNoteInducementShares_c20260126__20260127__us-gaap--LongtermDebtTypeAxis__custom--Jan272026SPAMember_zRfB8zukYUrl">1,050,000</span> shares of the Company’s common stock to the investor <span style="background-color: white">with a relative fair value of $<span id="xdx_90F_ecustom--SharesIssuedForNoteInducement_c20260126__20260127__us-gaap--LongtermDebtTypeAxis__custom--Jan272026SPAMember_zskNqaMcqno">23,445</span> which was recorded as a discount on the note</span>. The promissory note is convertible into common stock of the Company at any time after the date of issuance at a conversion price equal to 70% of the lowest closing price of the Company’s common stock on its principal trading market during the 10 trading days preceding the date of conversion. As a result of the variable conversion rate the conversion feature must be separated from the note resulting in derivative liability accounting under ASC 815. The fair value of the derivative on the date of issuance was recorded as a debt discount up to the face value of the note with the excess being charged directly to interest expense. See further discussion under “Note 8. <span style="text-decoration: underline">Derivative Liabilities</span>.” The aggregate debt discount of $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20260127__us-gaap--LongtermDebtTypeAxis__custom--Jan272026SPAMember_zBdMbUot5c6h">94,875</span> is being amortized to interest expense over the respective term of the note. As of June 30, 2026, the balance on the note is $<span id="xdx_903_eus-gaap--ConvertibleNotesPayable_iI_c20260630__us-gaap--LongtermDebtTypeAxis__custom--Jan272026SPAMember_zxvnbeR6r7oa">94,875</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 24, 2026, the Company entered into a securities purchase agreement with an accredited investor. Pursuant to the securities purchase agreement, the Company sold the investor an original issue discount promissory note in the principal amount of $<span id="xdx_908_eus-gaap--ConvertibleNotesPayable_iI_c20260224__us-gaap--LongtermDebtTypeAxis__custom--Feb2026SPAMember_zo7VkebcD2l2">150,000</span> for which the Company received net proceeds of $<span id="xdx_90B_eus-gaap--ProceedsFromConvertibleDebt_c20260223__20260224__us-gaap--LongtermDebtTypeAxis__custom--Feb2026SPAMember_zSkDkGF14PNa">130,000</span>. The promissory note carries an interest rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20260224__us-gaap--LongtermDebtTypeAxis__custom--Feb2026SPAMember_zfyvAtp10es2">6</span>% per annum and has maturity date of <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20260223__20260224__us-gaap--LongtermDebtTypeAxis__custom--Feb2026SPAMember_z5ziHna8usA1">February 24, 2027</span>. The promissory note is convertible into shares of the Company’s common stock 180 days after issuance at a price equal to 60% of the lowest traded price of the Company’s common stock on its principal trading market during the 15 trading days preceding the date of conversion. The aggregate debt discount of $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20260224__us-gaap--LongtermDebtTypeAxis__custom--Feb2026SPAMember_zi4louDmrYz5">20,000</span> is being amortized to interest expense over the respective term of the note. As of June 30, 2026, the balance on the note is $<span id="xdx_90B_eus-gaap--ConvertibleNotesPayable_iI_c20260630__us-gaap--LongtermDebtTypeAxis__custom--Feb2026SPAMember_zc0plf6eRc3k">150,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 5, 2026, the Company entered into a securities purchase agreement with an accredited investor. Pursuant to the securities purchase agreement, the Company sold the investor an original issue discount promissory note in the principal amount of $<span id="xdx_90F_eus-gaap--ConvertibleNotesPayable_iI_c20260305__us-gaap--LongtermDebtTypeAxis__custom--Mar2026SPAMember_z0UqUovxiFZ1">120,000</span> for which the Company received net proceeds of $<span id="xdx_909_eus-gaap--ProceedsFromConvertibleDebt_c20260304__20260305__us-gaap--LongtermDebtTypeAxis__custom--Mar2026SPAMember_zFxDDWJMhcq7">92,000</span>. The promissory note carries a one-time interest charge of 15% which is added to the principal balance, payable in four payments on September 15, 2026, October 15, 2026, November 15, 2026 and December 15, 2026 or upon acceleration or prepayment of the promissory note. The note is convertible into common shares of the Company upon an event of default, at a rate of 61% of the lowest price for the preceding 20 trading days. The aggregate debt discount of $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20260305__us-gaap--LongtermDebtTypeAxis__custom--Mar2026SPAMember_z0MnQyZMPh82">46,000</span> is being amortized to interest expense over the respective term of the note. As of June 30, 2026, the balance on the note is $<span id="xdx_90E_eus-gaap--ConvertibleNotesPayable_iI_c20260630__us-gaap--LongtermDebtTypeAxis__custom--Mar2026SPAMember_zbJG7bpl0rh">138,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On May 20, 2026, the Company entered into a securities purchase agreement with an accredited investor, pursuant to which the Company sold an unsecured original issue discount promissory note in the principal amount of $<span id="xdx_90F_eus-gaap--ConvertibleNotesPayable_iI_c20260520__us-gaap--LongtermDebtTypeAxis__custom--May2026SPAMember_z49dS36kr7kb">97,750</span> for which the Company received net proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20260519__20260520__us-gaap--LongtermDebtTypeAxis__custom--May2026SPAMember_zl226wShprtk">85,000</span> </span>after original issue discount of $<span id="xdx_904_eus-gaap--PaymentsOfDebtIssuanceCosts_c20260519__20260520__us-gaap--LongtermDebtTypeAxis__custom--May2026SPAMember__us-gaap--TransactionTypeAxis__custom--OriginalIssueDiscountMember_z2nhoSNXuzsc" title="Payment of debt issuance costs">12,750</span><span style="background-color: white">. </span>The promissory note shall incur a one-time interest charge of 10% equal to $<span id="xdx_900_eus-gaap--InterestExpenseDebt_c20260519__20260520__us-gaap--LongtermDebtTypeAxis__custom--May2026SPAMember_zreAFMywVeP6">12,750</span>, which is added to the principal balance, and has a maturity date of <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20260519__20260520__us-gaap--LongtermDebtTypeAxis__custom--May2026SPAMember_zA7WFNHTTnlf">May 20, 2027</span>. The note is convertible into common shares of the Company, at a rate of $0.01 and if after 180 days, the trading price is below $0.01 for 5 consecutive trading days the conversion price resets to $0.0075; if the trading price falls below $0.0075 for 5 consecutive days, the fixed price is eliminated and re-adjusted every 21 days. As a result of the variable conversion rate on the other outstanding notes, the conversion feature must be separated from the note resulting in derivative liability accounting under ASC 815. The fair value of the derivative on the date of issuance was recorded as a debt discount. See further discussion under “Note 8. <span style="text-decoration: underline">Derivative Liabilities</span>.” The aggregate debt discount of $<span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20260520__us-gaap--LongtermDebtTypeAxis__custom--May2026SPAMember_zNoHQl8QSzU7">50,227</span> is being amortized to interest expense over the respective term of the note. As of June 30, 2026, the balance on the note is $<span id="xdx_90D_eus-gaap--ConvertibleNotesPayable_iI_c20260630__us-gaap--LongtermDebtTypeAxis__custom--May2026SPAMember_zig58tp0kAak">110,500</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 3, 2026, we issued a convertible promissory note to an accredited investor in the aggregate principal amount of $<span id="xdx_90F_eus-gaap--ConvertibleNotesPayable_iI_c20260603__us-gaap--LongtermDebtTypeAxis__custom--June2026ConvNotePayableMember_zB4wOPlXkZr">300,000</span>. The Company received net proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_c20260602__20260603__us-gaap--LongtermDebtTypeAxis__custom--June2026ConvNotePayableMember_z3jNjbtE4twf">250,000</span> after original discount of $<span id="xdx_903_eus-gaap--PaymentsOfDebtIssuanceCosts_c20260602__20260603__us-gaap--LongtermDebtTypeAxis__custom--June2026ConvNotePayableMember__us-gaap--TransactionTypeAxis__custom--OriginalIssueDiscountMember_zCwzrtF3YuBj" title="Payment of debt issuance costs">50,000</span>. The promissory note shall incur a one-time interest charge of 12% equal to $<span id="xdx_908_eus-gaap--InterestExpenseDebt_c20260602__20260603__us-gaap--LongtermDebtTypeAxis__custom--June2026ConvNotePayableMember_zoWQ6gHQFHi9">50,000</span>, which is added to the principal balance and matures on <span id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_dd_c20260602__20260603__us-gaap--LongtermDebtTypeAxis__custom--June2026ConvNotePayableMember_zASVaucRv0dg">August 3, 2026</span>. After 180 days, the note is convertible at a price of $0.01 per share and, in the event that, 180 days after the date of issuance, the closing price of our common stock is less than $0.01 per share for more than five consecutive trading days, the conversion price shall reset to $0.0075. The aggregate debt discount of $<span id="xdx_90F_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20260603__us-gaap--LongtermDebtTypeAxis__custom--June2026ConvNotePayableMember_zQoHYgvHTiyc">100,000</span> is being amortized to interest expense over the respective term of the note. As of June 30, 2026, the balance on the note is $<span id="xdx_902_eus-gaap--ConvertibleNotesPayable_iI_c20260630__us-gaap--LongtermDebtTypeAxis__custom--June2026ConvNotePayableMember_zwsVGx80E0j">350,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the six months ended June 30, 2026 and 2025, the Company recorded debt discount amortization expense of $<span id="xdx_908_eus-gaap--AmortizationOfDebtDiscountPremium_c20260101__20260630_z0B51U2NnxP2" title="Amortization of debt discount">752,794</span> and $<span id="xdx_901_eus-gaap--AmortizationOfDebtDiscountPremium_c20250101__20250630_za8m72hoqM0d">0</span>, respectively and expects to amortize the remaining $<span id="xdx_90D_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20260630_z9iBMcyME01f">424,301</span> of discount over the remaining maturities of the outstanding notes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 35000 81600 60000 13600 8000 12240 2026-05-16 33840 53840 40000 172500 150000 22500 20700 2026-08-31 43200 96600 99000 190800 81600 60000 13600 8000 21600 123580 29740 287500 244000 37500 6000 28750 2026-09-15 8500000 174517 316250 178125 138125 115000 94000 15000 6000 9200 2026-09-18 3400000 121000 93950 30250 143750 119000 18750 6000 14375 2026-09-23 4250000 71400 158125 79063 127500 109688 143750 119000 18750 6000 14375 2026-09-23 4250000 71400 158125 79063 71500 165688 287500 250000 37500 34500 2026-08-31 17000000 178620 16120 322000 20000 2026-10-08 0.10 20000 115000 100000 15000 13800 2026-08-31 28800 128800 143750 125000 18750 18750 2026-11-20 1250000 25794 63294 162500 81250 71000 0.12 2027-01-12 10250 81250 86250 72500 8625 2027-01-27 1050000 23445 94875 94875 150000 130000 0.06 2027-02-24 20000 150000 120000 92000 46000 138000 97750 85000 12750 12750 2027-05-20 50227 110500 300000 250000 50000 50000 2026-08-03 100000 350000 752794 0 424301 <p id="xdx_809_eus-gaap--DerivativesAndFairValueTextBlock_zRdR35Zf3gkl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 8 – <span id="xdx_828_zaJoV8XskeXi">Derivative Liabilities</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair values of the conversion option of outstanding convertible notes payable and common stock warrants were determined to be derivative liabilities under ASC 815 due to the default on convertible notes payable disclosed above, which resulted in a variable conversion price on the outstanding convertible note payable. The fair value of the derivative liabilities was estimated using a binomial model with the following assumptions:</p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfServicingLiabilitiesAtFairValueTextBlock_znKPjASQs7si" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Derivative Liabilities (Details - Fair value of derivative liabilities)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BA_zX2BtElBkm6j" style="display: none">Schedule of assumptions for derivative liabilities</span></td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of June 30, 2026</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conversion Option</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 68%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_zgqlP5yUbv81" title="Exercise price">307.67%</span></span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zgF2uzug9jpe" title="Exercise price">307.67%</span></span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend Yield</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_zT4MICcJdL71" title="Exercise price">0%</span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zfcBUV9DGx44" title="Exercise price">0%</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free rate</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_z2xmReZGjug3" title="Exercise price">3.98%</span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_z1BLoEjG4OAg" title="Exercise price">3.98%</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_zX7AseGyT1E1" title="Exercise price">1 year</span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zaGGRJvwZs7j" title="Exercise price">1 year</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock price</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_zwLkP0Bz5oh1" title="Stock price">0.0038</span></span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zsLXJF1rI75f" title="Stock price">0.0038</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise price</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_z0dlMPc4MKH6" title="Exercise price">0.00077-0.01</span></span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zAcCqQj60XWg" title="Exercise price">0.01-0.5</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability fair value</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeLiability_pp0p0_c20260630__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_zS5oekMmOeHi" style="text-align: right" title="Derivative liability fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,160,849</span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98B_eus-gaap--DerivativeFairValueOfDerivativeLiability_pp0p0_c20260630__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zaEIgxULXoL8" style="text-align: right" title="Derivative liability fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">664,066</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of shares issued upon conversion, exercise, or satisfaction of required conditions as of June 30, 2026</span></td> <td> </td> <td> </td> <td id="xdx_98A_ecustom--SharesIssuedUponConversionExerciseSatisfaction_iI_c20260630__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_z9vGCYgLIcSh" style="text-align: right" title="Number of shares issued upon conversion, exercise, or satisfaction"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">901,421,462</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98F_ecustom--SharesIssuedUponConversionExerciseSatisfaction_iI_c20260630__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zhkuiDUNgUk5" style="text-align: right" title="Number of shares issued upon conversion, exercise, or satisfaction"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">216,800,000</span></td> <td> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Derivative Liabilities (Details - Fair value of derivative liabilities)"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2025</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Conversion Option</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="3" style="text-align: justify"> </td><td> </td> <td colspan="3" style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Volatility</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_908_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_z91ZuIQO018c" title="Exercise price">762.08%</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90C_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zQUpPoNPrqCc" title="Exercise price">762.08%</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Dividend Yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_zpm8015mxlnk" title="Exercise price">0%</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zAKLpcVTibl5" title="Exercise price">0%</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Risk-free rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_z9TIKVJr3rdg" title="Exercise price">3.48%</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zvvDbRntM6Vj" title="Exercise price">3.48%</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Expected term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_zTbzVaKySKO6" title="Exercise price">1 year</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zvt4NtY2JAl7" title="Exercise price">1 year</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Stock price</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_zQf9cTCkCPS8" style="text-align: right" title="Exercise price">0.041</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zVP01C5iZwg6" style="text-align: right" title="Exercise price">0.041</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Exercise price</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_zvoSV8q6Hruk" style="text-align: right" title="Exercise price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zflCjtbNQKGj" title="Exercise price">0.01-0.5</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Derivative liability fair value</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--DerivativeFairValueOfDerivativeLiability_c20251231__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_pp0p0" style="text-align: right" title="Derivative liability fair value">3,100,316</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--DerivativeFairValueOfDerivativeLiability_c20251231__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_pp0p0" style="text-align: right" title="Derivative liability fair value">12,324,245</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: justify">Number of shares issued upon conversion, exercise, or satisfaction of required conditions as of December 31, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--SharesIssuedUponConversionExerciseSatisfaction_c20251231__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_pdd" style="text-align: right" title="Number of shares issued upon conversion, exercise, or satisfaction">75,670,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--SharesIssuedUponConversionExerciseSatisfaction_c20251231__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_pdd" style="text-align: right" title="Number of shares issued upon conversion, exercise, or satisfaction">300,800,000</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A7_zqgvALciUjqa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All fair value measurements related to the derivative liabilities are considered significant unobservable inputs (Level 3) under the fair value hierarchy of ASC 820.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The table below presents the change in the fair value of the derivative liability during the six months ended June 30, 2026:</p> <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zulmMHDTgy8i" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Derivative Liabilities (Details - Change in the fair value of derivative liabilities)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B7_zXkKcSXp2b94" style="display: none">Schedule of fair value of derivative liability</span></td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 84%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value as of December 31, 2025</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_988_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_iS_c20260101__20260630_zwEawleiyCZb" style="width: 13%; text-align: right" title="Fair value of derivative liability, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,424,561</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Establishment of derivative liability upon issuance of notes and date they became convertible</span></td> <td> </td> <td> </td> <td id="xdx_981_ecustom--EstablishmentOfDerivativeLiabilityUponIssuanceOfNotes_pp0p0_c20260101__20260630_zXuS8jFLVZRi" style="text-align: right" title="Establishment of derivative liability upon issuance of notes and date they became convertible"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,230,805</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Extinguishment due to conversion</span></td> <td> </td> <td> </td> <td id="xdx_986_ecustom--ExtinguishmentDueToConversion_pp0p0_c20260101__20260630_zNly4Of8PWTi" style="text-align: right" title="Extinguishment due to conversion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,246,049</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Extinguishment due to repayment</span></td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--PaymentsOfDebtExtinguishmentCosts_iN_pp0p0_di_c20260101__20260630_zvO4DuCd6Rdf" style="text-align: right" title="Extinguishment due to repayment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(68,412</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Extinguishment due to exercise of warrants</span></td> <td> </td> <td> </td> <td id="xdx_98F_ecustom--ExtinguishmentDueToExerciseOfWarrants_pp0p0_c20260101__20260630_zVpHmyrs2hk6" style="text-align: right" title="Extinguishment due to exercise of warrants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,565,487</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value of derivatives</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98E_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_pp0p0_c20260101__20260630_zrM2F0QrFYU1" style="border-bottom: black 1pt solid; text-align: right" title="Change in fair value of derivatives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,950,503</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value as of June 30, 2026</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_iE_pp0p0_c20260101__20260630_zxbzXR7Fymwg" style="border-bottom: black 2.25pt double; text-align: right" title="Fair value of derivative liability, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,824,915</span></td> <td> </td></tr> </table> <p id="xdx_8AE_z9k5DRb6drEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The total impact of derivative liabilities recognized in the Company’s consolidated statements of operations includes the change in fair value of derivatives and the fair value of the derivative settled upon repayment, with the Company recognizing a net loss of $<span id="xdx_908_eus-gaap--DerivativeGainLossOnDerivativeNet_pp0p0_di_c20260401__20260630_ziZJnfK4AJLk" title="Gain loss on derivative liabilities">705,807</span> for the three months ended June 30, 2026, and a total gain of $<span id="xdx_90D_eus-gaap--DerivativeGainLossOnDerivativeNet_pp0p0_c20260101__20260630_zT7sx55IKkJ5" title="Gain loss on derivative liabilities">9,018,915</span> during the six months ended June 30, 2026. In addition, as a result of the default, all other potentially dilutive instruments must also be recorded at fair value pursuant to ASC 815.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfServicingLiabilitiesAtFairValueTextBlock_znKPjASQs7si" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Derivative Liabilities (Details - Fair value of derivative liabilities)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BA_zX2BtElBkm6j" style="display: none">Schedule of assumptions for derivative liabilities</span></td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of June 30, 2026</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conversion Option</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 68%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_zgqlP5yUbv81" title="Exercise price">307.67%</span></span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zgF2uzug9jpe" title="Exercise price">307.67%</span></span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend Yield</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_zT4MICcJdL71" title="Exercise price">0%</span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zfcBUV9DGx44" title="Exercise price">0%</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free rate</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_z2xmReZGjug3" title="Exercise price">3.98%</span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_z1BLoEjG4OAg" title="Exercise price">3.98%</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_zX7AseGyT1E1" title="Exercise price">1 year</span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zaGGRJvwZs7j" title="Exercise price">1 year</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock price</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_zwLkP0Bz5oh1" title="Stock price">0.0038</span></span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zsLXJF1rI75f" title="Stock price">0.0038</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise price</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_z0dlMPc4MKH6" title="Exercise price">0.00077-0.01</span></span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zAcCqQj60XWg" title="Exercise price">0.01-0.5</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability fair value</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98A_eus-gaap--DerivativeFairValueOfDerivativeLiability_pp0p0_c20260630__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_zS5oekMmOeHi" style="text-align: right" title="Derivative liability fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,160,849</span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98B_eus-gaap--DerivativeFairValueOfDerivativeLiability_pp0p0_c20260630__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zaEIgxULXoL8" style="text-align: right" title="Derivative liability fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">664,066</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of shares issued upon conversion, exercise, or satisfaction of required conditions as of June 30, 2026</span></td> <td> </td> <td> </td> <td id="xdx_98A_ecustom--SharesIssuedUponConversionExerciseSatisfaction_iI_c20260630__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_z9vGCYgLIcSh" style="text-align: right" title="Number of shares issued upon conversion, exercise, or satisfaction"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">901,421,462</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98F_ecustom--SharesIssuedUponConversionExerciseSatisfaction_iI_c20260630__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zhkuiDUNgUk5" style="text-align: right" title="Number of shares issued upon conversion, exercise, or satisfaction"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">216,800,000</span></td> <td> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Derivative Liabilities (Details - Fair value of derivative liabilities)"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2025</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Conversion Option</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="3" style="text-align: justify"> </td><td> </td> <td colspan="3" style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Volatility</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_908_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_z91ZuIQO018c" title="Exercise price">762.08%</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90C_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zQUpPoNPrqCc" title="Exercise price">762.08%</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Dividend Yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_zpm8015mxlnk" title="Exercise price">0%</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zAKLpcVTibl5" title="Exercise price">0%</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Risk-free rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_z9TIKVJr3rdg" title="Exercise price">3.48%</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zvvDbRntM6Vj" title="Exercise price">3.48%</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Expected term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_zTbzVaKySKO6" title="Exercise price">1 year</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zvt4NtY2JAl7" title="Exercise price">1 year</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Stock price</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_zQf9cTCkCPS8" style="text-align: right" title="Exercise price">0.041</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zVP01C5iZwg6" style="text-align: right" title="Exercise price">0.041</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Exercise price</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_zvoSV8q6Hruk" style="text-align: right" title="Exercise price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20250101__20251231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_zflCjtbNQKGj" title="Exercise price">0.01-0.5</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Derivative liability fair value</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--DerivativeFairValueOfDerivativeLiability_c20251231__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_pp0p0" style="text-align: right" title="Derivative liability fair value">3,100,316</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--DerivativeFairValueOfDerivativeLiability_c20251231__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_pp0p0" style="text-align: right" title="Derivative liability fair value">12,324,245</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: justify">Number of shares issued upon conversion, exercise, or satisfaction of required conditions as of December 31, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--SharesIssuedUponConversionExerciseSatisfaction_c20251231__us-gaap--DerivativeInstrumentRiskAxis__custom--ConversionOptionMember_pdd" style="text-align: right" title="Number of shares issued upon conversion, exercise, or satisfaction">75,670,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--SharesIssuedUponConversionExerciseSatisfaction_c20251231__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsMember_pdd" style="text-align: right" title="Number of shares issued upon conversion, exercise, or satisfaction">300,800,000</td><td style="text-align: left"> </td></tr> </table> 307.67% 307.67% 0% 0% 3.98% 3.98% 1 year 1 year 0.0038 0.0038 0.00077-0.01 0.01-0.5 3160849 664066 901421462 216800000 762.08% 762.08% 0% 0% 3.48% 3.48% 1 year 1 year 0.041 0.041 0.01 0.01-0.5 3100316 12324245 75670000 300800000 <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zulmMHDTgy8i" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Derivative Liabilities (Details - Change in the fair value of derivative liabilities)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B7_zXkKcSXp2b94" style="display: none">Schedule of fair value of derivative liability</span></td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 84%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value as of December 31, 2025</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_988_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_iS_c20260101__20260630_zwEawleiyCZb" style="width: 13%; text-align: right" title="Fair value of derivative liability, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,424,561</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Establishment of derivative liability upon issuance of notes and date they became convertible</span></td> <td> </td> <td> </td> <td id="xdx_981_ecustom--EstablishmentOfDerivativeLiabilityUponIssuanceOfNotes_pp0p0_c20260101__20260630_zXuS8jFLVZRi" style="text-align: right" title="Establishment of derivative liability upon issuance of notes and date they became convertible"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,230,805</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Extinguishment due to conversion</span></td> <td> </td> <td> </td> <td id="xdx_986_ecustom--ExtinguishmentDueToConversion_pp0p0_c20260101__20260630_zNly4Of8PWTi" style="text-align: right" title="Extinguishment due to conversion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,246,049</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Extinguishment due to repayment</span></td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--PaymentsOfDebtExtinguishmentCosts_iN_pp0p0_di_c20260101__20260630_zvO4DuCd6Rdf" style="text-align: right" title="Extinguishment due to repayment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(68,412</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Extinguishment due to exercise of warrants</span></td> <td> </td> <td> </td> <td id="xdx_98F_ecustom--ExtinguishmentDueToExerciseOfWarrants_pp0p0_c20260101__20260630_zVpHmyrs2hk6" style="text-align: right" title="Extinguishment due to exercise of warrants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,565,487</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value of derivatives</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98E_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_pp0p0_c20260101__20260630_zrM2F0QrFYU1" style="border-bottom: black 1pt solid; text-align: right" title="Change in fair value of derivatives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,950,503</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value as of June 30, 2026</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_iE_pp0p0_c20260101__20260630_zxbzXR7Fymwg" style="border-bottom: black 2.25pt double; text-align: right" title="Fair value of derivative liability, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,824,915</span></td> <td> </td></tr> </table> 15424561 1230805 -1246049 68412 -2565487 -8950503 3824915 -705807 9018915 <p id="xdx_802_eus-gaap--LesseeOperatingLeasesTextBlock_zJZtGQezPwpg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 9. <span id="xdx_829_z33fe4CjhyCd">Leases</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 6, 2024, the Company entered into a lease to lease its operating and office facility under a non-cancelable real property lease agreement that expired on May 31, 2026. The real property lease contains provisions requiring payment of property taxes, utilities, insurance, maintenance and other occupancy costs applicable to the leased premise. As the Company’s leases do not provide implicit discount rates, the Company uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The components of lease expense were as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--LeaseCostTableTextBlock_zlvi20GnJwmi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details - Lease expense)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8BE_zOSYFyqDLLkf" style="display: none">Schedule of lease expense</span></td><td> </td> <td colspan="3" id="xdx_49C_20260401__20260630_z3d98nAUvlr" style="text-align: center"> </td><td> </td> <td colspan="3" id="xdx_49D_20260101__20260630_zxaEhO1LN7tb" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>For the <br/>Three Months Ended June 30, 2026</b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>For the <br/>Six Months Ended June 30, 2026</b></td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseCost_zcrJWqMFIwy8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify; padding-bottom: 1pt">Operating lease cost</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">24,806</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">42,190</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LeaseCost_zpLM0baiHW4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total net lease cost</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">24,806</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">42,190</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zl3oPHdEy0Fb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Supplemental balance sheet information related to leases was as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--SupplementalBalanceSheetDisclosuresTableTextBlock_zkjiL1ItY9nh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details - Supplemental balance sheet info)"> <tr style="vertical-align: bottom"> <td style="text-align: justify; width: 83%"><span id="xdx_8B6_z7WwnJ6dGxV3" style="display: none">Schedule of supplemental balance sheet information</span></td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 13%"> </td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>For the<br/> Six Months Ended<br/> June 30, 2026</b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: justify">Operating leases:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 83%; text-align: justify">Operating lease assets</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20260630_zAswkhNzRLEh" style="width: 13%; text-align: right" title="Operating lease assets">85,454</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Current portion of operating lease liabilities</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--OperatingLeaseLiabilityCurrent_iI_c20260630_zLPGE18N9TC3" style="text-align: right" title="Current portion of operating lease liabilities">90,693</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Noncurrent operating lease liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_d0_c20260630_zeRfoth0LLc6" style="border-bottom: Black 1pt solid; text-align: right" title="Noncurrent operating lease liabilities">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total operating lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--OperatingLeaseLiability_iI_c20260630_ziUPtjnEYag5" style="border-bottom: Black 2.5pt double; text-align: right" title="Total operating lease liabilities">90,693</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Weighted average remaining lease term:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Operating leases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20260630_zGkNGerGmSMc" title="Weighted average remaining lease term operating leases">0.93</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Weighted average discount rate:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Operating leases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--LesseeOperatingLeaseDiscountRate_iI_dp_c20260630_zl5sZ8eO52i4" title="Weighted average discount rate operating lease">7.9</span>%</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A3_zT8YpT58Ggjd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Supplemental cash flow and other information related to leases was as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_zDMQtm76Ei9e" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details - Supplemental cash flow info)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; width: 83%"><span id="xdx_8B7_zGp0QJNcKce4" style="display: none">Schedule of supplemental cash flow information</span></td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%"> </td><td id="xdx_499_20260101__20260630_zsDJ4YyW6za5" style="text-align: center; width: 13%"> </td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom"> <td><b> </b></td><td><b> </b></td> <td colspan="3" style="text-align: center"><b>For the</b></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><b> </b></td><td><b> </b></td> <td colspan="3" style="text-align: center"><b>Six Months Ended</b></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: justify"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>June 30, 2026</b></td></tr> <tr id="xdx_40F_ecustom--CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_iB_zZBDzJlTbQ2i" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Cash paid for amounts included in the measurement of lease liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--OperatingLeasePaymentsUse_d0_zY42D8n23L01" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Operating cash flows used for operating leases</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--FinanceLeasePrincipalPayments_d0_zQ2RmUcMHm3c" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Financing cash flows used for finance leases</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--LeasedAssetsObtainedInExchangeForLeaseLiabilitiesAbstract_iB_zaw2hkOZFADl" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Leased assets obtained in exchange for lease liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_zGTswhtuFxP1" style="vertical-align: bottom; background-color: White"> <td style="width: 83%; text-align: justify; padding-bottom: 2.5pt">Total operating lease liabilities</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right">119,961</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_d0_zQlne5foujt9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total finance lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zv4GnMHsa6fd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following is a maturity analysis of the annual undiscounted cash flows of the operating lease liabilities on a fiscal year basis, including common area maintenance fees, under non-cancelable operating leases as of June 30, 2026: </p> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zFRG6dMZsbM5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details - Maturity analysis)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B1_zseVMiX5dyE" style="display: none">Schedule of maturity analysis operating leases</span></td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><b>Fiscal Year Ending</b></td><td><b> </b></td> <td colspan="3" style="text-align: center"><b>Minimum Lease</b></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center"><b>December 31,</b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>Commitments</b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">2026 (6 months)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_c20260630_zQUn9LPX7roa" style="width: 13%; text-align: right" title="2026 (6 months)">33,445</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20260630_zwI05EHZcr99" style="text-align: right" title="2027">61,841</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">2028</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_d0_c20260630_zYiNWu6o1lwd" style="text-align: right" title="2028">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2029</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_d0_c20260630_zWZyBCLc4ag7" style="text-align: right" title="2029">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">2030</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_d0_c20260630_zmhrFGevlLV" style="border-bottom: Black 1pt solid; text-align: right" title="2030">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total future undiscounted lease payments</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_d0_c20260630_zsPdd539tjG4" style="text-align: right" title="Total future undiscounted lease payments">95,286</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Less interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260630_z1RJlBD1ZHr3" style="border-bottom: Black 1pt solid; text-align: right" title="Less interest">(4,593</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Present value of lease payments</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--OperatingLeaseLiability_iI_c20260630_zgjvGsrJxL49" style="text-align: right" title="Present value of lease payments">90,693</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingLeaseLiabilityCurrent_iI_c20260630_zrrPjox4diKc" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">90,693</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Long-term operating lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_d0_c20260630_zRXvcTN1l8V4" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-term operating lease liabilities">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zDhUDNRWqRp5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--LeaseCostTableTextBlock_zlvi20GnJwmi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details - Lease expense)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8BE_zOSYFyqDLLkf" style="display: none">Schedule of lease expense</span></td><td> </td> <td colspan="3" id="xdx_49C_20260401__20260630_z3d98nAUvlr" style="text-align: center"> </td><td> </td> <td colspan="3" id="xdx_49D_20260101__20260630_zxaEhO1LN7tb" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>For the <br/>Three Months Ended June 30, 2026</b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>For the <br/>Six Months Ended June 30, 2026</b></td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseCost_zcrJWqMFIwy8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify; padding-bottom: 1pt">Operating lease cost</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">24,806</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">42,190</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LeaseCost_zpLM0baiHW4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total net lease cost</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">24,806</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">42,190</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 24806 42190 24806 42190 <table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--SupplementalBalanceSheetDisclosuresTableTextBlock_zkjiL1ItY9nh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details - Supplemental balance sheet info)"> <tr style="vertical-align: bottom"> <td style="text-align: justify; width: 83%"><span id="xdx_8B6_z7WwnJ6dGxV3" style="display: none">Schedule of supplemental balance sheet information</span></td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 13%"> </td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>For the<br/> Six Months Ended<br/> June 30, 2026</b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: justify">Operating leases:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 83%; text-align: justify">Operating lease assets</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20260630_zAswkhNzRLEh" style="width: 13%; text-align: right" title="Operating lease assets">85,454</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Current portion of operating lease liabilities</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--OperatingLeaseLiabilityCurrent_iI_c20260630_zLPGE18N9TC3" style="text-align: right" title="Current portion of operating lease liabilities">90,693</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Noncurrent operating lease liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_d0_c20260630_zeRfoth0LLc6" style="border-bottom: Black 1pt solid; text-align: right" title="Noncurrent operating lease liabilities">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total operating lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--OperatingLeaseLiability_iI_c20260630_ziUPtjnEYag5" style="border-bottom: Black 2.5pt double; text-align: right" title="Total operating lease liabilities">90,693</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Weighted average remaining lease term:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Operating leases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20260630_zGkNGerGmSMc" title="Weighted average remaining lease term operating leases">0.93</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Weighted average discount rate:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Operating leases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--LesseeOperatingLeaseDiscountRate_iI_dp_c20260630_zl5sZ8eO52i4" title="Weighted average discount rate operating lease">7.9</span>%</td><td style="text-align: left"> </td></tr> </table> 85454 90693 0 90693 P0Y11M4D 0.079 <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_zDMQtm76Ei9e" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details - Supplemental cash flow info)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; width: 83%"><span id="xdx_8B7_zGp0QJNcKce4" style="display: none">Schedule of supplemental cash flow information</span></td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%"> </td><td id="xdx_499_20260101__20260630_zsDJ4YyW6za5" style="text-align: center; width: 13%"> </td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom"> <td><b> </b></td><td><b> </b></td> <td colspan="3" style="text-align: center"><b>For the</b></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><b> </b></td><td><b> </b></td> <td colspan="3" style="text-align: center"><b>Six Months Ended</b></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: justify"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>June 30, 2026</b></td></tr> <tr id="xdx_40F_ecustom--CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_iB_zZBDzJlTbQ2i" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Cash paid for amounts included in the measurement of lease liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--OperatingLeasePaymentsUse_d0_zY42D8n23L01" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Operating cash flows used for operating leases</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--FinanceLeasePrincipalPayments_d0_zQ2RmUcMHm3c" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Financing cash flows used for finance leases</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--LeasedAssetsObtainedInExchangeForLeaseLiabilitiesAbstract_iB_zaw2hkOZFADl" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Leased assets obtained in exchange for lease liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_zGTswhtuFxP1" style="vertical-align: bottom; background-color: White"> <td style="width: 83%; text-align: justify; padding-bottom: 2.5pt">Total operating lease liabilities</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right">119,961</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_d0_zQlne5foujt9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total finance lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 0 0 119961 0 <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zFRG6dMZsbM5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details - Maturity analysis)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B1_zseVMiX5dyE" style="display: none">Schedule of maturity analysis operating leases</span></td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><b>Fiscal Year Ending</b></td><td><b> </b></td> <td colspan="3" style="text-align: center"><b>Minimum Lease</b></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center"><b>December 31,</b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>Commitments</b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">2026 (6 months)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_c20260630_zQUn9LPX7roa" style="width: 13%; text-align: right" title="2026 (6 months)">33,445</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20260630_zwI05EHZcr99" style="text-align: right" title="2027">61,841</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">2028</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_d0_c20260630_zYiNWu6o1lwd" style="text-align: right" title="2028">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2029</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_d0_c20260630_zWZyBCLc4ag7" style="text-align: right" title="2029">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">2030</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_d0_c20260630_zmhrFGevlLV" style="border-bottom: Black 1pt solid; text-align: right" title="2030">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total future undiscounted lease payments</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_d0_c20260630_zsPdd539tjG4" style="text-align: right" title="Total future undiscounted lease payments">95,286</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Less interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260630_z1RJlBD1ZHr3" style="border-bottom: Black 1pt solid; text-align: right" title="Less interest">(4,593</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Present value of lease payments</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--OperatingLeaseLiability_iI_c20260630_zgjvGsrJxL49" style="text-align: right" title="Present value of lease payments">90,693</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingLeaseLiabilityCurrent_iI_c20260630_zrrPjox4diKc" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">90,693</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Long-term operating lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_d0_c20260630_zRXvcTN1l8V4" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-term operating lease liabilities">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 33445 61841 0 0 0 95286 4593 90693 90693 0 <p id="xdx_80E_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zYqeMvmjWotk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 10. <span id="xdx_82A_zGD6JtcqCCK9">Commitments and Contingencies</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Legal Contingencies</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 8, 2022, the Company was notified of a potential lawsuit related to the termination of our Advisory Panel Membership agreement with Taylor Black Wealth, Ltd. (“Taylor”). The Company engaged Taylor for assistance with capital raises and was to be partially compensated with stock options, subject to vesting. Taylor claims that the Company terminated the agreement unlawfully and therefore are still entitled to the remaining unvested options which the Company believes to be cancelled. The total number of stock options being contested is 137,473, which are still shown as issued and outstanding in Note 6 “<span style="text-decoration: underline">Equity</span>” above.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As disclosed under Note 4, the Employment Agreement between the Company and Dr. Adler was terminated following the Company’s discovery that SAPL and ACL breached material representations and warranties under the Share Exchange. Pursuant to a letter dated December 8, 2025, the Company intends to seek rescission of the Share Exchange and rescind the shares of Company common stock issued to ACL pursuant to the Share Exchange. The Company has also sent notice to Dr. Adler for the termination of the option to purchase common stock issued to Dr. Adler under the Employment Agreement and the termination of such agreement for “cause” as defined under the agreement. Among other material breaches, without limitation, the Company has discovered that the real property and material assets of SAPL were encumbered at the time of the closing of the Share Exchange and remain encumbered and subject to liens.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Florida Litigation</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 15, 2026, the Company filed a lawsuit against SAPL and ACL in the United States District Court for the Southern District of Florida. The Company is seeking rescission of the Share Exchange and temporary injunctive relief to prevent SAPL and ACL from transferring the shares of common stock received pursuant to the Share Exchange and damages related thereto. SAPL and ACL have since filed a counterclaim and may bring additional claims.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, the trial is scheduled for July 2027. The Company is unable to predict the outcome of the litigation or estimate the ultimate financial exposure, if any, that may result from the proceedings. An adverse judgment or settlement could have a material adverse effect on the financial condition and results of operations of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Nevada Litigation</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 16, 2026, ACL filed a verified shareholder derivative action in the District Court of Clark County, Nevada against the Company’s directors, Charles Faulkner and Simon Wajcenberg, as well as the Company as a nominal defendant. The complaint alleges breaches of fiduciary duty, fraud, violations of the Nevada Securities Act, equity dilution, conversion, unjust enrichment, and civil conspiracy in connection with the Series D Preferred Stock issuance, executive compensation, and SEC filings. The relief sought includes compensatory and punitive damages, disgorgement, injunctive relief, appointment of a receiver, and a judicial declaration that the Series D Preferred Stock issuance was invalid. The Company and its directors moved to dismiss the case. On July 9, 2026, the court heard arguments and granted dismissal of the lawsuit. A formal order of dismissal was entered on August 10, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p id="xdx_80A_eus-gaap--SubsequentEventsTextBlock_zyYQPIRn74Pe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 11 – <span id="xdx_825_zMpYuNhalQO5">Subsequent Events</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Common Share issuances</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsequent to June 30, 2026, the Company has issued 8,392,077 shares of restricted common stock to a private investor for cash proceeds of $25,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsequent to June 30, 2026, the Company has issued 503,178,900 shares of common stock for the conversion of $357,578 in principal on outstanding convertible notes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Authorized Share Increase</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsequent to June 30, 2026, and effective August 13, 2026, the Company filed a certificate of amendment to its Articles of Incorporation, as amended, increasing the Company’s authorized shares of common stock from 7,000,000,000 to 56,000,000,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> false false false false